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CHAPTER ONE. General Introduction 
Thesis Organization  
This dissertation follows the alternative format of thesis organization and each journal 
paper appears as a separate chapter in the thesis. Since the thesis is a complete and cohesive 
document, the first chapter is a general introduction, including literature review of previous 
works of others, unsolved research problems, specific aims and hypotheses of research 
projects, and the significance of the research topic. The manuscripts have been formatted and 
included as chapter two, three, and four. These manuscripts are either published or going to 
be submitted for publication. The last chapter is a general conclusion chapter summarizing 
and discussing the results of all three manuscripts as they apply to the research problems 
detailed in the general introduction.  
Literature Review  
In this part, the immunobiology of dendritic cells, previous research results on the 
function of dendritic cells in mycobacteria infections, characteristics of Mycobacterium 
avium subspecies paratuberculosis (M. paratuberculosis), and host innate and adaptive 
immune responses against M. paratuberculosis infection were reviewed. Since M. 
paratuberculosis infection induces granulomatous lesions, the last part of this review was on 
granuloma general information and the involvement of dendritic cells (DC) in the formation 
of granuloma.  
In the section discussing DC immunology, the commonly accepted categorization of 
DC, DC differentiation, typical pattern of surface marker and chemokine receptor expression 
on DC, maturation of DC, and the capacity of DC to initiate and regulate T cell immune 
responses were reviewed.  
Dendritic Cells 
Dendritic cells, as antigen capturing cells in innate immunity, are among the first line 
defense against pathogen infection. Dendritic cells (DC) are the most potent antigen 
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presenting cells, which can induce primary immune response, naïve T cell activation, and 
initiate adaptive immune responses. Besides initiation of immune response, DC are also 
active regulators of immune responses by producing pro-inflammatory and anti-
inflammatory cytokines (Banchereau et al., 2000; Hope et al., 2003; Howard et al., 2004; 
Iyonaga et al., 2002).  
Immature DC are active antigen capturing cells and use several pathways for antigen 
uptake, including macropinocytosis, receptor-mediated endocytosis via C-type lectin 
receptors (mannose receptor, CD205) (Mommaas et al., 1999; Tan et al., 1997) or Fcγ 
receptor type I (CD64) and II (CD32), and phagocytosis of particles such as viruses, bacteria 
including mycobacteria (Inaba et al., 1993; Rescigno et al., 1999), and parasites. Immature 
DC use a variety of pattern recognition receptors (i.e. TLRs) to recognize patterns shared 
between pathogens, such as bacterial lipopolysaccharide (LPS), peptidoglycan, and CpG 
oligodeoxynucleotide. After encountering the antigen or phagocytosis of a pathogen, 
immature DC start to process the antigen and load the antigenic peptide to MHC I (major 
histocompatibility complex, MHC), MHC II, or other non-classical MHC I molecules to be 
presented on the cell surface. CD1 and HLA-G are examples of non-classical MHC I 
molecules. Antigen-captured DC undergo maturation during their migration to the draining 
lymph node, the location where they encounter and present antigen to T cells. The main 
functions of fully mature immuno-stimulatory DC are antigen presentation, co-stimulatory 
signal provider, and cytokine secretor. Contrary to immature DC, mature DC are inefficient 
at antigen acquisition, hence uptake of fluorescent-labeled tracer molecules (FITC-Dextran 
or DQ-Ovalbumin) is often used as a functional measure of DC maturation. DC are different 
from other antigen presenting cells in that DC can induce naïve T cell proliferation. The 
mixed lymphocyte reaction (MLR) was first used as a test for possible graft compatibility 
in human transplantation, and now often used as a measure of responder T cell proliferation 
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against histocompatibility mismatch at the MHC locus on allogeneic stimulator DC, an 
indirect test for expression level of MHC I and MHC II molecules on DC surface. 
Mature DC present antigenic peptide to T lymphocytes and initiate adaptive immune 
response. Also, DC are able to promote the polarization of immune response to Th1 (T helper 
cell type 1) or Th2 types. There are several factors shown to influence the polarization of Th1 
or Th2 type of immune response, including the dose of antigen, antigen affinity to TCR, the 
nature of the antigen, and strength and duration of signaling (Rogers and Croft, 1999).  Some 
studies suggest that polarization of dendritic cells influence Th1 or Th2 lineage 
differentiation (Rissoan et al., 1999). Binding of pathogen-associated molecular patterns 
(PAMPs) to Toll-like receptors (TLRs) expressed on DC and subsequent TLRs interaction 
with their adaptor proteins are able to skew specific immune response towards the Th1 or 
Th2 type. Diffenret antigenic stimulation determines DC polarization by signaling through 
different TLRs or other PAMPs recognizing receptors expressed on DC (Amati et al., 2006). 
Following antigen capture and processing by dendritic cells, pathogen-derived antigenic 
peptide is presented through MHC II or MHC I to the TCR (T cell receptor) on naïve T 
lymphocytes. With the help of co-stimulatory molecules (CD80 and CD86) and also the third 
signal cytokines (IL-12, IL-10, IL-4, or IL-23) provided by antigen-encountered DC, T cells 
are activated and undergo further differentiation into several lineages (Figure 1). In the 
presence of IL-12, naïve CD4 T cells differentiate towards Th1 phenotype, which upregulate 
the key Th1 cytokine IFN-γ (interferon) expression via STAT4 (signal transducer and 
activator of transcription 4). IFN-γ binds to its receptor on T cells, activates STAT1, and lead 
to the induction of Th1 lineage determining transcription factor Tbet (Th1-specific T box 
transcription factor). IL-2 and TNF-β (tumor necrosis factor-β, lymphotoxin-α) are also two 
characteristic cytokines secreted during Th1-mediated responses. In the presence of IL-4, 
which activates STAT6 and induces transcription factor GATA3, naïve CD4 T cells 
differentiate into a Th2 lineage. Typical Th2 cells produce cytokines IL-4, IL-5, IL-6, IL-10, 
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and IL-13. Recently, CD4 T cells were shown to be able to develop into a third lineage, Th17 
cells. In humans, the Th17 cell subset develops in response to the presence of cytokines IL-
1β and TGF-β (transforming growth factor beta). While in mice, cytokines IL-6 and TGF-β 
are required for Th17 cell differention. IFN-γ and Th2 type cytokines inhibit differentiation 
of Th17 cells. Signaling via IL-6 activates STAT3 and induces Th17 lineage transcription 
factor RORγt (Stockinger and Veldhoen, 2007). IL-23 acts to expand previously 
differentiated Th17 cells. Th17 cells secret IL-17, IL-17F, IL-6, IL-22, TNF, and GM-CSF 
(granulocyte macrophage-colony stimulating factor) (Bettelli et al., 2007). Bacteria, but not 
viruses, primed human DCs can promote IL-17 production in memory Th cells through 
enhancing IL-23 and IL-1 production by DC (Zelante et al., 2007). IL-23/Th17 driven 
inflammation acts as a negative regulator of the Th1-mediated immune resistance to fungi 
and promotes infection (van Beelen et al., 2007). The exact effect of Th17 cells on DC is still 
unclear and is under investigation.  
DC are multifunctional cells in vivo under different conditions. DC function as strong 
inducers of innate and adaptive immunity to infections, tumor, and other antigens in vivo. 
DC can also function as a regulator or inhibitor of T cell immune response under certain 
conditions. At steady state, there is increasing evidence that DC induce antigen-specific 
unresponsiveness or tolerance in central lymphoid organ and in the periphery. Targeting DC 
antigen capture receptors (CD205, CD206, DC-SIGN, and CD209) with low dose of antigens 
in the steady state without maturation stimuli can induce these DC to undergo incomplete 
maturation resulting in subsequent deletion of the responding T cells, leading to 
unresponsiveness to recall antigen (Bonifaz et al., 2002; Dhodapkar et al., 2001; Hawiger et 
al., 2001; Liu et al., 2002; Menges et al., 2002). These DC are often called tolerogenic DC, 
which are critical in maintaining self-tolerance. Regulatory dendritic cells (regulatory DC) 
have an immature-like phenotype, secret high level IL-10, and initiate regulatory T cell 
differentiation. Regulatory T cells can differentiate from conventional CD4+ T cells under the 
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influence of DC (Wakkach et al., 2003). Immunosuppressive cytokine IL-10 can induce 
differentiation of regulatory DC(Morel et al., 2003; Steinman et al., 2003). Regulatory DC 
and regulatory T cells serve as a self-control mechanism in limiting the immune response to 
prevent immune-mediated tissue damage.  
Because of the plasticity of DC function under different inflammatory conditions, it is 
critical to consider the context in which DC will be used for immunotherapy. To establish a 
protective immune response against infectious agents or tumors, a successful DC-based 
vaccine needs to contain antigen-loaded, fully activated and matured DC along with 
inflammatory cytokines (Adema et al., 2005; Nestle et al., 2005). While incompletely 
matured, without costimulation, and/or IL-10, IL-4 producing DC can be used to achieve 
tolerance in the autoimmune condition or prior to organ transplantation (Morel et al., 2003).  
Origins, categories, and homeostasis of dendritic cells  
Because of the heterogeneity of DC in vivo and differences in DC biology between 
humans and other animal species, controversies remain in the dendritic cell categorization, 
origins, half-life in peripheral tissue, and the renewal mechanisms. 
Tissue DC can differentiate during embryonic development and during postnatal life 
from bone marrow-derived progenitors present in tissue or from peripheral blood monocytes. 
In contrast to the traditional view that DC are non-dividing, terminally differentiated cells 
renewed by circulating and local resident precursors, a recent study showed that tissue-
resident DC have limited proliferative properties that contribute to the maintainance of DC 
pool in the steady state (Liu et al., 2007). The homeostasis of tissue DC in the steady state is 
suggested to be maintained by a dynamic balance between replenishment from proliferation 
of local resident progenitor cells or from bone marrow cells, in situ limited numbers of DC 
division over 10-14 days (dermal DC, splenic DC), and DC death (Bogunovic et al., 2006; 
Fogg et al., 2006; Geissmann, 2007; Kabashima et al., 2005; Liu et al., 2007).   
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Many distinct DC subsets have been discovered since the initial description of DC by 
Steinman and Cohn in 1973 (Steinman and Cohn, 1973). Each of these DC subsets resides in 
a particular location and has a specialized function in the immune system (Shortman and Liu, 
2002).  All of them are capable of antigen uptake, processing, and presentation to naïve T 
cells. DC can be divided into conventional dendritic cells (cDC) and pre-dendritic cells (pre-
DC) (Shortman and Naik, 2007) (Figure 2). Pre-DC are the cells without immediate DC 
phenotype and function, but have the capacity to develop into DC with little or no division 
upon inflammatory or microbial stimuli. Monocytes and plasmacytoid DC (produce high 
levels of type I interferons after viral infection) are two examples of pre-DC. GM-CSF and 
IL-4 are two cytokines critical for monocyte differentiation into DC mainly shown in the in 
vitro culture system (Sallusto and Lanzavecchia, 1994). Conventional DC already have a 
characteristic DC phenotype/morphology with dendrites on the cell periphery and exhibit DC 
function in steady state. Most conventional DC originate directly from bone marrow-derived 
myeloid precursors (macrophage and DC precursor (MDP)), without a monocytic cell 
intermediate. Conventional DC can be further divided into migratory conventional DC and 
lymphoid-tissue-resident conventional DC. The migratory DC have the “text-book DC life 
history” (Banchereau et al., 2000; Shortman and Naik, 2007), sampling antigen in the 
periphery, then migrating to the draining lymph nodes through the lymphatic network with 
antigens while acquiring a mature phenotype, and eventually presenting antigen to naïve T 
cells. The migration of DC to the lymph nodes also occurs in steady state (in healthy 
individuals) at a very low rate, which possibly relates to the maintainance of peripheral 
tolerance (Huang and MacPherson, 2001). Typical migratory conventional DC include 
Langerhans cells and dermal DC in the skin. Lymphoid-tissue-resident conventional DC, as 
the other subtype of conventional DC, do not migrate but reside in one lymphoid organ 
(thymus, spleen, lymph node) throughout their life span (Ardavin, 1997; Vremec et al., 
2000). These cells collect and present foreign and self antigens within the resident lymphoid 
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organ. They can express one, both, or neither of CD4 and CD8 on the surface. Thymic DC 
and splenic DC are examples of lymphoid-tissue-resident DC. The origins of thymic DC and 
plasmacytoid DC are unclear, although they may develop, at least in part, from myeloid 
progenitor cells. All DC that are not normally present in steady state and appear upon 
inflammatory or infectious stimuli are called inflammatory DC. They can be differentiated 
from inflammatory monocytes, and express CD11c, but not CD4 or CD8 (Naik et al., 2006). 
Most research on DC has focused on migratory conventional DC and monocyte-derived DC. 
Throughout this dissertation, DC refers to these two types unless noted otherwise.  
Surface antigen expression  
Immature DC, located in peripheral tissues, express basal levels of MHC class I, 
MHC class II, CD205, and co-stimulatory molecules CD80 (B7.1), CD86 (B7.2) and CD40 
(Banchereau et al., 2000). Immature DC express CD1b and have high intracellular MHC II 
(MIICs). Ligands to the co-stimulatory molecules include CD28, CTLA-4 (CD152), and 
CD40L (CD40 ligand), which are expressed on resting and activated T cells. Ligation of 
costimulatory molecules to their ligands provides the second signal for T cells activation and 
proliferation, and is essential for initiation of a protective immune response. After antigen 
capture, processing, and DC maturation, DC surface expression of MHC II, MHC I, CD40, 
CD80, CD83, and CD86 are all increased (Banchereau et al., 2000). CD11c is a type 
I transmembrane protein found at high levels on most human dendritic cells, but also 
on monocytes, macrophages at relatively low levels. CD11c is a DC marker widely used 
human and murine DC research. CD205 (DEC205) belongs to the macrophage mannose 
receptor family of C-type lectin endocytic receptors and behaves as an antigen 
uptake/processing receptor for DC. Bovine immature DC were recently characterized to have 
a similar pattern of surface markers expression as DC from other species with some 
differences. Bovine immature DC express low CD14 and CD205, are positive for CD11c, 
in 
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MHC I, and MHC II expression (Bajer et al., 2003; Hope et al., 2003; Langelaar et al., 
2005b; Miyazawa et al., 2006; Norimatsu et al., 2003; Pinchuk et al., 2003).   
Chemokines and chemokine receptors  
Chemokines are a group of small proteins secreted by cells that guide the migration of 
other cells. Cells, expressing corresponding chemokine receptors, follow a chemotactic 
gradient of increasing chemokine concentration towards the source of the chemokine.  
Immature DC express high levels of chemokine receptor 1 (CCR1), CCR5, CCR6, 
and low levels of CCR7 on the cell surface. CCR5 is one of the receptors for chemokine 
macrophage inflammatory protein-1 alpha (MIP-1α). Following interaction with infectious 
and/or inflammatory stimuli, maturing and activated DC decrease expression of CCR5 and 
up-regulate CCR7 expression. Mature DC have a pattern of low CCR1, CCR5, CCR6, and 
high CCR7 expression on the surface. CCR7 receptor mediates migration toward secondary 
lymphoid organs including regional lymph nodes. Ligands for CCR7 are macrophage 
inflammatory protein-3 beta (MIP-3β) and secondary lymphoid organ chemokine (SLC) 
(Algood et al., 2003; Allavena et al., 2000; Pinchuk et al., 2003; Sallusto et al., 2000). 
Because of the distinct pattern of chemokine receptor expression on immature and mature 
DC, CCR5 and CCR7 have been reported as appropriate markers for DC maturation status 
(Buettner et al., 2005; Dulphy et al., 2007; Mariotti et al., 2002).   
Semi-mature dendritic cells and T cell immune response 
Recent findings suggest that there is a third maturation status of DC: semi-mature DC 
or licensed DC phenotype (Lutz and Schuler, 2002; Martin F. Bachmann1, 2006). Semi-
mature DC have undergone phenotypic changes consistent with maturation, however, they 
lack sufficient expression of co-stimulatory molecules and cytokine production to induce T 
cell responses. The phenotype of semi-mature DC is comparable to steady-state migratory 
DCs, which can continuously induce lymph node T cell tolerance to self-antigens and other 
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infectious agents (Lutz and Schuler, 2002). Semi-mature DC were shown to play a role in the 
expansion, activation, and differentiation of T cells that regulate or suppress other T cell 
response in the periphery after encounter with pathogens and foreign antigens (Mills and 
McGuirk, 2004).  
Pathogen-derived molecules signal through pattern recognition receptors (PRRs) 
expressed on DC and influence the capacity of DC to activate and modulate  naïve T cells 
differentiation into different lineages, including Th1, Th2, and regulatory T cells (d'Ostiani et 
al., 2000; Gagliardi et al., 2000; Hemmi et al., 2000; McGuirk et al., 2002; Moser and 
Murphy, 2000). Semi-mature DC, with enhanced MHC II but low costimulatory molecules, 
can present antigens to T cells and direct differentiation of regulatory T cells. Ineffective 
CD40 ligation has been associated with enhanced IL-10 secretion by DC, which is an 
important cytokine for regulatory T cell generation (Martin et al., 2003). It was shown that 
DC at the infection site can be influenced by the bacterial products and microenvironment 
resulting in dysfunctional antigen presentation with incomplete co-stimulatory signals to T 
lymphocytes (Howard et al., 2004). This may suggest that bacterial pathogens promote the 
generation of suboptimal T cell responses and/or regulatory T cell differentiation by signals 
through PRRs (Toll-like receptors, etc) expressed on DC surface. M. leprae and M. 
tuberculosis infect human monocyte-derived DC and result in limited activation and 
maturation of infected cells (Dulphy et al., 2007; Hanekom et al., 2003; Murray et al., 2007).  
Dendritic cells and mycobacteria infection 
Numerous studies have demonstrated the central role of cell mediated immunity in 
the host immune response and control of mycobacterial infections in humans and other 
animal species (Flynn and Chan, 2001; Giacomini et al., 2001). T lymphocytes and antigen-
presenting cells are the key players in the host anti-mycobacterial immune response. CD4 
and CD8 T lymphocytes promote bacterial clearance by producing IFN-γ to activate 
macrophages and also by direct cytolytic reaction. Antigen presenting cells (APC) are the 
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first immune cell type to encounter mycobacteria, and the interaction between APC and M. 
tuberculosis is a key feature determining the host resistance towards infection and further 
development as an active or latent disease.  
Mycobacteria express pathogen associated molecular patterns (PAMPs), such as 
lipoproteins and lipoglycans, that are recognized by Toll-like receptors (TLRs) expressed on 
APCs. Signaling through TLRs activates NF-κB pathway, induces IL-12 secretion, triggers 
the maturation of DC, and a Th1-oriented immune response (Brightbill et al., 1999; Hertz et 
al., 2001). DC-specific C-type lectin (DC-SIGN, CD209, DC-specific intercellular adhesion 
molecule 3 grabbing nonintegrin) is a member of PRRs and is the key receptor on DC for 
mycobacterial cell wall component mannosylated lipoarabinomannan (ManLAM) secreted by 
BCG and M. tuberculosis. ManLAM binding to DC-SIGN interferes with the signaling 
through TLRs that induce DC maturation, thus prevents mycobacteria induced DC 
maturation (Geijtenbeek et al., 2003). Whole bacterium M. tuberculosis infects DC, induces 
DC maturation, and a Th1 biased immune response, while mycobacterial derived product 
ManLAM targets DC-SIGN on non-infected by-stander DC during infection and induces a 
partial maturation or semi-mature phenotype on these DC (Dulphy et al., 2007).  
The most important and distinct function of macrophages is the rapid killing of 
phagocytosed organism in the phago-lysosome. However, it has been known for some time 
that mycobacteria can evade the phagosome-lysosome fusion pathway, persist and replicate 
within host macrophages (Glickman and Jacobs, 2001). Unlike M. tuberculosis infected 
macrophages, DC do not allow M. tuberculosis intracellular replication even though DC are 
unable to kill phagocytosed bacteria (Bodnar et al., 2001; Tailleux et al., 2003). Recent report 
showed that DC are more permissive for M. bovis replication than macrophages, but release 
high IL-12 and induce better antigen-specific T cell proliferation (Denis and Buddle, 2007). 
Overall, DC may serve as a reservoir for mycobacteria in vivo, particularly within the lymph 
nodes draining the primary infection site. Infection of DC with either M. tuberculosis or BCG 
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is associated with up-regulated MHC II, co-stimulatory molecules expression and increased 
pro-inflammatory cytokines IL-12, TNF-α, IL-1, IL-6, and also anti-inflammatory cytokine 
IL-10 production (Giacomini et al., 2001; Henderson et al., 1997; Hickman et al., 2002; Kim 
et al., 1999). IL-10 may inhibit the adaptive cellular response by down-regulating IL-12 
production and inducing regulatory T cell differentiation. 
Because of the significant differences in the disease, infection route, and lesion 
development caused by M. paratuberculosis or other mycobacteria, the results of the studies 
on the innate and adaptive immune responses and DC function during other mycobacteria 
infection can not directly be applied to M. paratuberculosis research.  
M. paratuberculosis infection usually occurs in neonatal animals at the 
gastrointestinal tract (Cocito et al., 1994). M cells may serve as the entry point for ingested 
M. paratuberculosis, and the microorganism can be expelled on the basolateral side of M cell 
and phagocytosed by subepithelial and intraepithelial macrophages or dendritic cells 
(Fujimura and Owen, 1996; Lugton, 1999; Momotani et al., 1988). Recent studies suggest 
that intestinal mucosal dendritic cells form transepithelial dendrites through adhesion 
between chemokine receptor CX3CR1 and fractalkine expressed on intestinal epithelial cells, 
and through this structure dendritic cells directly monitor the content in the intestine lumen 
(Maric et al., 1996; Niess et al., 2005; Rescigno et al., 2001). This is essential for pathogen 
clearance and tolerance maintenance. Intestinal dendritic cells can capture antigen in the 
lamina propria, below M cells, and also transport bacteria and protein directly from the 
intestine lumen (Macpherson and Uhr, 2004).Through both mechanisms, dendritic cells 
might be essential in initiating and shaping the immune response towards M. 
paratuberculosis. Little is know about interactions between M. paratuberculosis and 
dendritic cells. Untill now, there is only one study on live M. paratuberculosis infected 
bovine monocyte-derived DC cytokine gene expression via quantitative realtime RT-PCR 
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(Langelaar et al., 2005b). Further research needs to done to determine DC function in M. 
paratuberculosis infection.  
Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) 
M. paratuberculosis is an intracellular Gram-positive, acid-fast bacillus that was first 
identified by Johne and Frothingham in 1895 in the granulomatous lesions of cattle with 
chronic diarrhea. The organism was fully characterized several years later and named M. 
paratuberculosis. M. paratuberculosis causes disease in ruminants characterized by 
granulomatous enteritis. M. paratuberculosis infection is prevalent worldwide and causes 
significant economic loss each year (Harris and Barletta, 2001; Stabel, 1998). In 1996, a 
survey conducted by National Animal Health Monitoring System using serological analysis 
showed an estimate of 20-40% of US dairy herds had M. paratuberculosis infection (Wells et 
al., 1998). M. paratuberculosis can also infect monogastric species. Although still highly 
controversial, some studies link human Crohn’s disease with M. paratuberculosis, raising 
concern that current standard pasteurization may not be able to effectively kill M. 
paratuberculosis in milk (Chamberlin et al., 2001; Grant et al., 1998; Grant et al., 1999; 
Naser et al., 2002). The pathogenic role of M. paratuberculosis in human disease and the 
identification of possible sources of infection are still under investigation. 
Unsolved problems in M. paratuberculosis research  
Little is known about the early immune response after M. paratuberculosis infection 
in vivo. The early subclinical period after M. paratuberculosis infection is suggested to be 
associated with dominant cell mediated T-helper cell type 1 (Th1) immune response, which 
is the response essential to the control of intracellular pathogen infections, including M. 
paratuberculosis.  Development of clinical disease correlates with deterioration of cell 
mediated immune response, and leaves a dominant humoral (Th2) immune response 
(Burrells et al., 1998; Chiodini, 1996). Overlap exists between Th1 and Th2 response 
pathways at various time points during the course of mycobacterial pathogen infection (Jiao 
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et al., 2003; Ritacco et al., 1991). The nature of early immune response to M. 
paratuberculosis, the exact mechanisms responsible for the shift of balance between Th1 and 
Th2 response and development of clinical disease are still unclear. The role and function of 
dendritic cells, as the most potent antigen-presenting cell in inducing naïve T cell activation 
and initiation of adaptive immune response, in M. paratuberculosis infection remain to be 
studied. Vaccines for paratuberculosis have been commercially available for many years, but 
are not completely effective in preventing the disease (Chiodini et al., 1984; Cocito et al., 
1994; Kormendy, 1994; van Schaik et al., 1996). The vaccinated animals showed less severe 
symptoms but still shed bacteria. Most of these studies on paratuberculosis vaccine were field 
trials, in which the experimental design and conditions were not fully described or controlled. 
Better understanding of the immune response following vaccination will provide important 
information for future vaccine design. 
Characteristics of M. paratuberculosis 
Mycobacteria in general, Mycobacterium avium (M. avium) complex in particular, are 
a group of closely related microorganisms.  The M. avium complex is currently subdivided 
into M. avium subsp. avium (M. avium), M. avium subsp. paratuberculosis (M. 
paratuberculosis), M. intracellulare, and M. silvaticum. The subspecies in this complex share 
90% similarity in their nucleotide sequences (Motiwala et al., 2006). M. paratuberculosis can 
still be differentiated from M. avium, M. intracellulare, and M. silvaticum by its slow growth, 
its dependence on mycobactin to grow, and the presence of multiple copies of insertion 
element IS900 in its genome (Collins and de Lisle, 1986; Thorel et al., 1990).  
There are several major M. paratuberculosis-specific antigenic proteins that have 
been discovered, including GroES, GroEL, AhpC, AhpD, 32 kDa, 34 kDa, 34.5 kDa, 35 kDa, 
42 kDa, 44.3 kDa, and 65 kDa proteins (Cameron et al., 1994; Cobb and Frothingham, 1999; 
Coetsier et al., 1998; el-Zaatari et al., 1994; El-Zaatari et al., 1997; Mutharia et al., 1997; 
Olsen et al., 2000; White et al., 1994). The GroES proteins are highly antigenic and highly 
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conserved proteins. M. paratuberculosis GroES sequences are 100% identical to M. avium 
sequences, and 90% identical to the M. tuberculosis and M. leprae sequences (Cobb and 
Frothingham, 1999). The GroES protein M. tuberculosis homolog has two T cell epitopes, 
which are also conserved in M. paratuberculosis. Recently characterized alkyl hydroperoxide 
reductases C and D produced by M. paratuberculosis were shown to be able to stimulate 
peripheral blood mononuclear cells from M. paratuberculosis infected goats to produce 
interferon-gamma (IFN-γ) (Olsen et al., 2000).  
Initial M. paratuberculosis infection usually occurs in neonatal animals (Cocito et al., 
1994). The transmission of infection is often through fecal-oral route by ingesting of the 
organism through contaminated milk or accidental ingestion of fecal matter containing M. 
paratuberculosis. Intestinal macrophages and dendritic cells capture antigen in the lamina 
propria and induce T cell immune response against invading M. paratuberculosis.  
Innate Immune Response to M. paratuberculosis 
M. paratuberculosis infects macrophages and monocytes (Bendixen et al., 1981; 
Buergelt et al., 1978), and like other pathogenic mycobacteria, M. paratuberculosis can 
evade the aggressive defense mechanisms invoked following phagocytosis by host 
macrophages. Numerous studies have described the mechanisms that mycobacteria utilize to 
survive and replicate within macrophages. It was shown that M. paratuberculosis 
preferentially reside in phagosomes or early endosomes of host macrophages, by inhibiting 
the maturation of phagolysosome (Bendixen et al., 1981; Cheville et al., 2001; Kuehnel et al., 
2001; Momotani et al., 1988). Phagosomes containing live M. paratuberculosis had 
increased expression of an early phagosome marker transferring receptor (TFR) and 
decreased expression of a late maturation marker lysosome-associated membrane protein 1 
(LAMP-1) (Hostetter et al., 2003). Addition of macrophage activation reagents LPS and IFN-
γ resulted in increased acidification and maturation of M. paratuberculosis containing 
phagosomes, which suggests that activation status of infected macrophages relates to 
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phagosome maturation (Hostetter et al., 2002). The inhibition of phagosome maturation by 
M. tuberculosis was demonstrated to be mediated though mechanisms including reduced 
activity of macrophage sphingosine kinase (Kusner, 2005), and interaction between 
mycobacterial mannose-capped lipoarabinomannan (ManLAM) with macrophage mannose 
receptors, which results in limited phagolysosome fusion (Kang et al., 2005).  
M. tuberculosis and M. leprae infect human monocyte-derived dendritic cells and 
induce limited activation and maturation of infected DC (Dulphy et al., 2007; Murray et al., 
2007).  Little is known about interactions between M. paratuberculosis and dendritic cells.  
Specific molecular patterns in bacteria and bacterial components (PAMPs) are 
recognized by antigen presenting cells via PRRs, including TLRs, DC-SIGN, mannose 
receptor, and complement receptors (Akira and Takeda, 2004). Stimulation of different TLRs 
induces distinct patterns of gene expression, which not only leads to the activation of innate 
immunity but also instructs the development of antigen-specific acquired immunity. Host 
macrophages and dendritic cells sense the presence and characteristics of the pathogen they 
encounter and then provide the information to T lymphocytes and other cells to induce an 
appropriate immune response. Thirteen mammalian TLRs have been identified so far, 10 
human (TLR1–10) and 12 murine (TLR1–9 and TLR11–13) receptors (Albiger et al., 2007). 
Each of them recognizes specific microorganism components and has specific ligands. 
Mycobacterial components are mainly recognized by TLR2 (in association with TLR1/6, 
lipoarabinomannan, LAM), TLR9 (bacterial CpG-containing DNA), and TLR4 
(phosphatidyl-myo-inositol tetra- and hexamannosides, PIM4–6) (Abel et al., 2002; Akira and 
Takeda, 2004; Krutzik and Modlin, 2004). TLR2, TLR9, and TLR4 all have adaptor protein 
MyD88 binding to their cytoplasmic tail TIR (Toll-IL-1 receptor) after ligand binding has 
occurred. Besides MyD88, TLR2 also uses adaptor protein TIRAP (TIR-domain-containing 
adaptor protein; also known as MyD88-adaptor-like protein, MAL), and TLR4 uses TIRAP, 
TRIF (TIR-domain-containing adaptor protein inducing IFN-β; also known as TIR-domain-
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containing molecule 1, TICAM1), and TRAM (TRIF-related adaptor molecule; also known 
as TIR-domain-containing molecule 2, TICAM2) (Akira and Takeda, 2004). A recent study 
shows that dendritic cells predominantly use TLR9 signaling for the high level production of 
IL-12 in the presence of M. tuberculosis infection, while M. tuberculosis infected 
macrophage use only TLR2 signaling which lead to low level IL-12 production (Pompei et 
al., 2007). This report supports other studies that TLR2 is a not a good inducer of IL-12p40 
and IL-12p70, and indeed TLR2 favors Th2 responses (Agrawal et al., 2003; Re and 
Strominger, 2001; Re and Strominger, 2004).  
Extracellular ligand binding and cytoplasmic signaling through these TLRs and 
associated proteins can lead to activation and nuclear translocation of NF-κB (nuclear factor-
kappa B). NF-κB is the name for a transcription factor complex, including RelA (p65), RelB, 
C-Rel, NF-κB1 (p50), and NF-κB2 (p52) (Gilmore, 2006; Karin and Ben-Neriah, 2000).  
Many different signaling pathways can activate cytoplasmic NF-κB and they converge in the 
phosphorylation of IκB kinase (IKK) multisubunits. The inhibitor IκBα can then be 
phosphorylated by phosphorylated IKKα and IKKβ, become ubiquitinated, and degraded. 
The heterodimers RelA and NF-κB1, which previously are bound to IκBα, are able to 
translocate into the nucleus (Karin and Ben-Neriah, 2000; Li and Verma, 2002). NF-κB is 
shown to be involved in activation and transcription of a large number of genes in response 
to bacterial or viral antigens, inflammation, stress, UV irradiation, and free radicals. Many 
cytokines have promoter sequences for NF-κB transcription factor heterodimer binding, 
including IL-1 (Interleukin-1), IL-2, IL-4, IL-8, IL-12, TNF-α (tumor necrosis factor), and 
IFN-β (Caamano and Hunter, 2002). RelB is required for myeloid DC maturation and 
enhanced expression of CD40 and MHC II. DC from RelB-/- mice and RelB-silenced DC 
were shown to suppress a previously primed immune response through the induction of IL-
10 producing regulatory T cells (Li et al., 2007; Mills and McGuirk, 2004). The low levels of 
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CD40 and MHC II expression on DC in some pathogen infections may be partly due to the 
pathogen interference with NF-κB RelB function.  
Adaptive Immune Response to M. paratuberculosis and Cytokine Secretion  
Since pathogenic mycobacteria, including M. paratuberculosis, can evade host innate 
immune response and survive inside infected antigen presenting cells, adaptive immune 
response becomes vital for the control of these intracellular pathogen infections. The type of 
adaptive immune responses and the balance between different types during the infection 
directly relates to the outcome of the pathogen infection and disease development.  
Macrophages and dendritic cells are the first line defense against pathogens and most 
mycobacteria, including M. paratuberculosis. Once the infection establishes itself, host 
adaptive Th1 immune response is essential in the control of infection.  After initial exposure 
to M. paratuberculosis, host response is associated with dominant Th1 immune response, 
characterized by proinflammatory cytokines IFN-γ, IL-1α, and IL-6 secretion (Burrells et al., 
1999; Coussens, 2001; Khalifeh and Stabel, 2004a; Stabel, 1996; Sweeney et al., 1998). 
Peripheral blood mononuclear cells (PBMC) isolated from animals in the early stage of M. 
paratuberculosis infection, either naturally infected or experimentally infected, produce high 
levels of IFN-γ (Stabel, 2000a; Waters et al., 2003). In vitro IFN-γ  measurement has been 
successfully used to diagnose M. paratuberculosis infection in the early phase, and other 
mycobacterial infections, such as M. tuberculosis and M. bovis (Gwozdz et al., 2000; Huda et 
al., 2003; Stabel and Whitlock, 2001). Th0 (IFN-γ positive/IL-4 positive) cells were shown to 
be present in peripheral blood from animal with bovine tuberculosis. The higher ratio of Th0 
cells to Th1 cells was associated with disseminated pathology of the disease (Welsh et al., 
2005). During late phase of M. paratuberculosis infection, Th1 immune response wanes and 
humoral response becomes dominant, characterized by IgG1 (immunoglobulin) production 
(Coussens, 2001; Stabel, 2000b). The nature of early immune response to M. 
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paratuberculosis and the exact mechanisms responsible for the shift of balance between Th1 
and Th2 response are still unclear.  
IFN-γ is required to control mycobacteria infection in a number of species (Cooper et 
al., 1993; Flynn et al., 1993; Zurbrick et al., 1988). IFN-γ promotes macrophage and T cell 
activation, and dendritic cell maturation (Shankar et al., 2003). IFN-γ induces reactive 
oxygen and nitrogen intermediates production by activated macrophages (Sato et al., 1998). 
Antigen presenting cells express IFNGR (IFN-γ receptor), and upon ligation these cells 
secret IL-12 in a feedback way (Miro et al., 2006). Mice deficient in the IFN-γ receptor high-
affinity binding chain (IFNGR1) are highly susceptible to M. bovis Bacillus Calmette-Guerin 
(BCG) infection, with defects in granuloma formation and a fatal outcome (Kamijo et al., 
1993). It was also shown that mice with deletions of the genes for IFN-γ and IFN-γ 
regulatory factor 1 (IRF1) were unable to control BCG growth (Dalton et al., 1993; Kamijo 
et al., 1994). IL-12 and IL-18 are two IFN-γ regulating cytokines. Like IL-12, IL-23 
stimulates IFN-γ secretion and its activity is mainly to induce IFN-γ production in memory T 
cells (Lankford and Frucht, 2003). Heterodimeric cytokines IL-12 and IL-23 share subunit 
IL-12p40, and IL-12 also uses IL-12p35 subunit while IL-23 uses IL-12p19 subunit (Cooper 
et al., 2002).  
A previous study showed that a pattern of proinflammatory cytokine gene expression 
was increased in PBMC from cattle naturally infected with M. paratuberculosis, including 
IFN-γ, IL-1α, IL-6, and IL-8. Expression of TNF-α, TGF-β, IL-12p35, and IL-4 were 
significantly decreased in infected animals compared to control animals, while no difference 
was seen in IL-10 expression in the two groups (Coussens et al., 2004). Another study found 
IL-10 and TGF-β mRNA level were higher in intestinal tissue from M. paratuberculosis 
infected cattle than control cattle (Khalifeh and Stabel, 2004b). Low IL-12p35 mRNA level 
is consistent with the report that M. paratuberculosis infection does not appear to induce IL-
12 secretion (Berger and Griffin, 2006). IL-4 was shown to play a role in the inhibition of 
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IFN-γ production by Th1 CD4 T cells (Seo and Tokura, 1999). IL-4 and IL-10 both inhibit 
IFN-γ production by attenuating the transcriptional activation of both IFN-α and IFN-γ-
induced cellular genes expression, IP-10, ISG54, and ICAM-1 (intercellular adhesion 
molecule-1). The inhibition of these genes was accomplished by preventing the IFN-induced 
tyrosine phosphorylation of STAT1 (signal transducer and activation of transcription), which 
is a key transcription factor in IFN-γ production (Ito et al., 1999; Larner et al., 1993).  
High IL-10 and TGF-β level in M. paratuberculosis infected cattle intestine tissue 
were shown to play a role in the pathogenesis of M. paratuberculosis. Bovine monocyte-
derived dendritic cell and macrophage infected with M. paratuberculosis were shown to 
produce IL-10 (Langelaar et al., 2005b; Weiss et al., 2002). IL-10 over-expressed mice were 
unable to clear M. bovis BCG infection and had a high mycobacterial burden (Murray et al., 
1997). IL-10 knockout mice showed increased anti-mycobacterial immunity and lower 
bacterial burden (Murray and Young, 1999). TGF-β acts as a regulatory cytokine via 
inhibition of T cell activation and proliferation, also down-regulation of IFN-γ secretion by T 
cells (Ludviksson et al., 2000). TGF-β inhibits M. avium infected macrophage and M. 
paratuberculosis infected PBMC bacterial killing activity (Bermudez, 1993; Khalifeh and 
Stabel, 2004a).  
Inflammatory cytokine TNF-α plays a major role in the control of acute and chronic 
mycobacterial infection. TNF-α is important in macrophage activation (Clark, 2007), 
immune cell recruitment to the infection site, especially granuloma formation and 
organization (Ehlers, 2005; Lin et al., 2007). Besides infected macrophages, dendritic cells 
are also producers of TNF-α during intracellular pathogen infection (Serbina et al., 2003; 
Tam and Wick, 2004). TNF-α acts as a positive feedback signal on infected DC and 
macrophage to secret more TNF-α, chemokines CCL2 (monocyte chemotactic protein-1, 
MCP-1) and CXCL10, IL-1, and IL-18. These cytokines and chemokines drive the 
infiltration of CD4+ T cells, CD8+ T cells, monocytes, neutrophils, and natural killer (NK) 
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cells (Algood et al., 2003). Recruited immune cells produce cytokines and chemokines that 
amplify the cascade of cell infiltration to infection site and formation of granuloma (Flynn 
and Chan, 2005; Ulrichs and Kaufmann, 2006). TNF-/- single gene knockout mice infected 
with M. tuberculosis succumbed to infection, with widespread dissemination of M. 
tuberculosis.  Instead of forming localized granulomas containing activated macrophages and 
T cells, cellular infiltrates in TNF-/- mice were poorly organized (Bean et al., 1999; Lin et al., 
2007). Since M. paratuberculosis induces a loosely organized and diffuse granuloma, the 
role of TNF-α in M. paratuberculosis infection is of great interest.  
However, overproduction of IFN-γ and other proinflammatory cytokines can cause 
severe tissue damage and lesion formation. Th2 mediators are important in maintaining the 
Th1/Th2 balance and preventing immunopathology caused by uncontrolled proinflammatory 
cytokines secretion. The proper balance between Th1 and Th2 cytokine responses are critical 
in the control of mycobacteria infection while maintaining the host organ function intact at 
the same time.  
Regulatory T cells (Treg cells) 
Pathogen infection often induces strong cell mediated and humoral immune 
responses, which will result in severe tissue damage and immunopathology if no regulatory 
mechanisms exist. However, regulatory T cells may facilitate the survival of certain 
intracellular pathogen by dampening the existing immune response prior to the complete 
clearance of that pathogen.  
There are several types of regulatory cells, some of which are induced upon infectious 
challenge, and some are considered natural regulatory cells. Natural regulatory T cells 
(Foxp3+ CD4+ CD25+) arise during thymus T cell development and maturation process, and 
survive in the periphery as Treg cells in healthy human and animals. Natural Treg cells 
constitutively express a specific set of markers, including CD25, CTLA-4 (cytotoxic T-
lymphocyte-associated protein 4), and GITR (glucocorticoid-inducible tumor necrosis factor 
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receptor) (Fontenot and Rudensky, 2005; Piccirillo and Shevach, 2004). Transcription factor 
Foxp3 is required for natural Treg cells generation and is the most specific marker for these 
type of cells (Fontenot and Rudensky, 2005). Natural Treg cells respond to many different 
self-antigens, and may also respond to microbial antigens. Natural Treg cells cannot produce 
IL-2 or proliferate in vitro (Sakaguchi, 2005). Treg cells mediate suppression by cell-contact-
dependent mechanism and/or suppressive cytokines secretion. Treg cells may promote IL-10 
and TGF-β production by other T cells and also by themselves (Sakaguchi, 2005).  
Inducible regulatory T cells are generated from conventional CD4+ T cells under 
different conditions in the periphery. Several types of inducible regulatory T cells have been 
reported, including TR1 (T regulatory cell type 1), Th3 (T helper cell type 3), and iTreg 
(induced Treg cell) (Figure 1). T cells differentiate into TR1 cells (IL-2low/- IL-4- IL-5+ IL-10+ 
TGF-β+) after encounter antigen in the presence of IL-10 (Groux et al., 1997). TR1 cells carry 
out their regulatory function on immune responses through the secretion of the 
immunosuppressive IL-10 and TGF-β. TR1 cells suppress both naïve and memory T cell 
responses (Roncarolo et al., 2006). Antigen presenting cell co-stimulatory molecule 
expression and pro-inflammatory cytokine production are regulated by TR1 cells. T helper 
cell type 3 (Th3) cells are another type of regulatory T cells differentiated from CD4+ CD25- 
T cells in the presence of TGF-β (Walker et al., 2003). Th3 regulatory cells secrete high level 
of TGF-β and mediate cell-contact dependent suppression on existing immune response. 
iTreg (CD4+ CD25+ Foxp3+ TGF-β+) cells can be generated ex vivo from CD4+CD25- T cell 
population under various conditions, such as encountering antigen in the presence of 
immunosuppressive cytokines IL-10 and TGF-β, CD40-CD40 ligand blockage, or by 
immature, semi-mature dendritic cell populations (Barrat et al., 2002; Wakkach et al., 2003; 
Zheng et al., 2002). The induction of iTreg cells is independent of CD28-B7 costimulatory 
signals. iTreg cells function in vitro and in vivo generally in a cytokine-dependent manner 
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(TGF-β). Dendritic cells can expand antigen-specific Foxp3+ CD4+ CD25+ regulatory T cells 
(Yamazaki et al., 2006).  
Regulatory T cells can migrate to infection site and act on controlling the balance of 
Th1/Th2 immune responses. This regulatory function is critical to prevent the 
immunopathology and tissue damage associated with chronic infectious disease. However, 
too many regulatory T cells appearing too early in the infection may result in insufficient 
immune response and incomplete clearance of the invading pathogen. A recent study showed 
that in the ileum of cattle naturally infected by M. paratuberculosis, a higher percentage of 
CD4+ CD25+ T cells and lower percentage of CD2+ CD62L+ T cells existed in the infected 
animals as compared to noninfected controls (Weiss et al., 2006).  Lymphocytes isolated 
from M. paratuberculosis infected cattle ileum proliferated poorly in response to M. 
paratuberculosis antigens, concanavalin A, and pokeweed mitogen. Taken together, these 
results suggest that the accumulated CD4+ CD25+ T cells exert suppression on lymphocytes 
response and inhibit the control of M. paratuberculosis infection in intestine.  
Granuloma  
Granuloma formation represents a chronic localized inflammatory reaction in 
response to certain foreign material (non-immune granuloma) and pathogens (immune 
granuloma), including a variety of bacteria (mycobacteria), fungi, and parasites (Chensue et 
al., 1999; Chiu et al., 2004; Hagge et al., 2004; Saunders and Britton, 2007). Classic 
granulomatous inflammation is characterized by dense accumulation of macrophages, 
lymphocytes, epitheloid cells (generally considered to represent activated macrophages), and 
fibroblasts in the periphery (Kaufmann, 1993; Sandor et al., 2003). Recently, dendritic cells 
were shown to be present in the experimental BCG or beads (pathogenic antigens coated) 
induced granulomatous lesions (Chiu et al., 2004; Iyonaga et al., 2002; Tsuchiya et al., 
2002).  Lesions that are classified as granulomas have diverse structure, cell infiltration, and 
organization. Generally, granulomas can be divided into two types. Type one (tuberculoid 
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granuloma) has the classic, well-organized, well-differentiated granuloma structure, with 
epitheloid and multi-nucleated giant cells containing few acid-fast bacilli, surrounded by 
lymphocytes and fibrous tissue, in some cases a necrotic center. M. tuberculosis generally 
induces formation of type one granulomas. Type two (lepromatous granuloma) has the 
opposite poorly-organized, ill-defined granuloma, with few if any giant cells and 
lymphocytes, wide-spread macrophages loaded with acid-fast microorganisms. The 
granulomatous lesions in M. paratuberculosis infection are often in this category. M. leprae 
infection can induce both tuberculoid and lepromatous types of granulomas.  
The cytokine TNF-α was shown to be critical in maintaining the organized granuloma 
structure (Lin et al., 2007). Tuberculosis reactivation has occurred subsequent to the anti-
TNF therapy (Infliximab and Adalimumab) in the patients with rheumatoid arthritis, Crohn’s 
disease, and psoriasis (Ehlers, 2005; Hueber and McInnes, 2007; Lin et al., 2007; Plessner et 
al., 2007). These anti-TNF treated patients often have extrapulmonary or disseminated 
tuberculosis. These observations confirm the essential role of TNF-α in maintaining the 
granuloma structure and control of M. tuberculosis infection.  
The fact that most granulomas are associated with T cell mediated immunity has been 
known for a long time (Algood et al., 2003; Flynn et al., 1993; Yoneyama et al., 2001). It 
was not until recently that researchers started to study the presence and role of dendritic cells 
in the granulomatous inflammation. Interestingly, dendritic cells were found to contribute to 
the development and regulation of granulomas in the liver and lung (Chiu et al., 2004; 
Iyonaga et al., 2002; Ordway et al., 2005; Yoneyama et al., 2001).  One study utilized the 
model of granulomas induced by beads-coated with pathogenic antigens, M. bovis purified 
protein derivative (PPD) or Schistosoma mansoni soluble egg antigens (SEA). Both PPD- 
and SEA-coated beads induced lesions with similar level TNF-α production, while PPD-
beads resulted in a biased IL-1, IL-6, and IL-12 expression. CD11c+ DC were shown to 
present in the granulomatous lesions from both groups and were of comparable maturation 
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status. Transfer of DC from PPD-bead lesion conferred a Th1 cytokine response in the 
recipients, suggesting lung DC recruited under inflammatory conditions favor a Th1 immune 
response (Chiu et al., 2004). This finding is consistent with the theory that the cytokine 
environment in which DC are in and the type of antigens to which they are exposed to 
determine the type of T cell response these DC elicit (Liu et al., 2001). Foamy cells inside 
granuloma express DC marker CD11c, CD205, and a high level of MHC II, CD40, TNFR-
associated factor 1(TRAF-1), TRAF-2, and TRAF-3, which are markers associated with 
resistance to apoptosis (Ordway et al., 2005). The formation of intestinal granuloma depends 
on a unique CD11c+ DC-like cell subset that exhibits features of immature myeloid DC and 
expresses F4/80 (a macrophage marker) (Mizoguchi et al., 2007). These intestinal 
granuloma-involved DC produce large amounts of IL-23 and directly induce granuloma 
formation.  
All of these studies suggest that dendritic cells may play a critical role in the 
formation and organization of the granulomatous lesions in M. paratuberculosis infection.  
Specific Aims 
M. paratuberculosis infection is wide spread throughout the world, causes significant 
economic losses each year, and is a public health concern. Understanding of the host immune 
response against M. paratuberculosis infection would provide important information for the 
control and prevention of M. paratuberculosis infection. The subclinical period after M. 
paratuberculosis infection was shown to be associated with dominant cell mediated Th1 
immune response. This anti-intracellular pathogen Th1 response wanes during the course the 
disease and leaves a dominant humoral Th2 immune response. The nature of early immune 
response to M. paratuberculosis and the exact mechanisms responsible for the shift of 
balance between Th1 and Th2 are still unclear.  
Dendritic cells, as the most potent antigen-presenting cell in inducing naïve T cell 
activation and initiating adaptive immune response, may play a critical role in shaping the 
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immune response and maintaining the balance between the Th1/Th2 responses towards M. 
paratuberculosis infection. Little information is available describing how M. 
paratuberculosis infection affects dendritic cell function and the role of dendritic cells in the 
formation of M. paratuberculosis granuloma. Investigating the maturation and function of 
dendritic cells in M. paratuberculosis infection are essential in understanding the 
pathogenesis of the infection, which ultimately help to the control of this disease.  
To study the early immune response and DC function following M. paratuberculosis 
infection, both in vitro and in vivo models of M. paratuberculosis infection were used. 
Phenotypic and functional changes in infected DC, and DC cytokine responses after exposure 
to M. paratuberculosis were characterized. M. paratuberculosis strain 19698 was utilized as 
bacterial inoculum. Also, the mechanisms of commercial M. paratuberculosis vaccine in 
shaping the host immune response and DC function upon subsequent M. paratuberculosis 
challenge were studied.  
Specific Aim One 
Determine the phenotype, function, and maturation status of bovine monocyte-
derived dendritic cells following M. paratuberculosis infection in vitro. 
Specific aim one hypothesis 
Bovine dendritic cells are permissive to infection with M. paratuberculosis and full 
activation and maturation of M. paratuberculosis infected bovine DC are impaired. 
Until now, very limited information has been available describing the phenotype, 
function, and maturation status of M. paratuberculosis whole bacteria infected dendritic 
cells. There is one report on the cytokine gene expression in bovine monocyte-derived DC 
infected with M. paratuberculosis via realtime qRT-PCR (Langelaar et al., 2005b). Healthy 
steers were used in the following studies. Peripheral blood mononuclear cells were isolated 
and labeled for CD14 magnetic cell isolation. Isolated CD14+ monocytes were then cultured 
with GM-CSF and IL-4 cytokines to generate dendritic cells. Dendritic cells were infected in 
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vitro with M. paratuberculosis whole bacteria and used for phenotypic and functional 
analysis as listed below:  
1. Determined the phagocytosis of M. paratuberculosis by bovine dendritic cells 
using transmission electron microscopy and fluorescence labeling.  
2. Evaluated surface marker expression by flow cytometry, and co-stimulatory 
molecule and chemokine receptor gene expression via realtime qRT-PCR.  
3. Quantified infected DC endocytosis ability using fluorescence-labeled ovalbumin 
endocytosis assay.  
4. Determined the ability of infected DC to produce pro- and anti-inflammatory 
cytokines and to induce T lymphocyte proliferation. 
Specific Aim Two 
Determine the phenotypic and functional features of CD11c+ DC-like cells in 
granulomatous lesion induced by M. paratuberculosis infection in vivo.  
Specific aim two hypothesis 
In vivo, dendritic cells recovered from M. paratuberculosis-induced granulomas have 
impaired activation and maturation, thus are defective in the initiation of a sustainable and 
protective Th1 immune response locally.  
Dendritic cell phenotype and function within M. paratuberculosis induced granuloma 
are still unknown. We tested whether our in vitro work results could be generalized to an in 
vivo subcutaneous M. paratuberculosis infection experiment system. The calves received live 
M. paratuberculosis by subcutaneous injection on the neck. Palpable granulomas were 
observed at injection sites seven days after inoculation. Granulomas were then removed 
surgically and granuloma cells were isolated by collagenase treatment and homogenization. 
CD11c+ cells were isolated from total granuloma cells through magnetic cell separation or 
laser capture microdissection. In the following studies, we analyzed the phenotypic and 
 27
functional features of CD11c+ DC-like cells recovered from M. paratuberculosis induced 
granuloma. 
1. Examined granuloma cell composition by flow cytometry, histology and 
immunohistochemistry. 
2. Analyzed granuloma cell cytokine gene expression via realtime qRT-PCR. 
3. Analyzed surface marker expression on CD11c+ antigen presenting cell isolated 
from M. paratuberculosis induced granuloma via flow cytometry, and 
costimulatory molecules, chemokine receptor, and cytokine gene expression using 
realtime RT-PCR. 
4. Determined the ability of CD11c+ antigen presenting cell isolated from M. 
paratuberculosis granuloma to induce antigen-specific CD4+ T lymphocyte 
proliferation and cytokine production.  
Specific Aim Three 
Analyze the function of CD11c+ DC-like cells recovered from lymph node draining 
granulomatous lesions of vaccinated or non-vaccinated calves challenged with M. 
paratuberculosis. 
Specific aim three hypothesis 
Vaccination status affects phenotype and function of CD11c+ DC-like cells in lymph 
node draining granulomatous lesions following M. paratuberculosis challenge. 
Commercial vaccines for paratuberculosis have been available for many years; 
however, these vaccines are not completely effective in preventing the disease. Most studies 
on paratuberculosis vaccine were field trials, in which the experimental design and 
conditions were not fully described or controlled. Understanding the mechanisms of M. 
paratuberculosis vaccine in shaping the host immune response and the function of DC to 
subsequent M. paratuberculosis challenge will provide critical information for future vaccine 
design. In the following studies, we used 4-6 weeks old calves vaccinated or non-vaccinated 
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followed by M. paratuberculosis subcutaneous challenge. CD11c+ cells were isolated by 
magnetic cell isolation from the lymph nodes draining M. paratuberculosis induced 
granulomatous lesions in either vaccinated or non-vaccinated animals. The following 
approaches were used to evaluate function and phenotype of granuloma CD11c+ cells.  
1. Examined the cell composition of lymph node draining M. paratuberculosis 
challenge site by flow cytometry.  
2. Determined the surface marker expression on isolated CD11c+ cells.   
3. Examined the ability of draining lymph node CD11c+ cells to induce antigen-
specific CD4 and CD8 T cell proliferation. 
4. Analyzed the ability of granuloma draining lymph node CD11c+ cells to promote 
cytokine production by themselves and also other cell types.  
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Figure 1.  Differentiation of CD4+ T cell lineages. Peripheral naïve CD4+ T cell precursor 
cells (ThP) can differentiate into three subsets of effector T cells (Th1, Th2, and Th17) and 
several subsets of regulatory T cells, including induced Treg cells (iTreg), TR1 cells (T 
regulatory cell type 1), and Th3 cells (T helper cell type 3). Naturally occurring Treg cells 
(nTreg) are generated from CD4+ thymic T cell precursors. The differentiation of these 
subsets is governed by selective cytokines and transcription factors, and each subset has its 
specialized functions and produces selective cytokines.  
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Figure 1.  Differentiation of CD4+ T cell lineages.  
Adapted from Bettelli E., Oukka M., and Kuchroo V. K., Nature Immunology 8 (2007) 345-
350.  
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Figure 2.  Categories of dendritic cells. DC can be divided into conventional dendritic cells 
(cDC) and pre-dendritic cells (pre-DC). Monocytes and plasmacytoid DC (pDC) are two 
examples of pre-DC. GM-CSF and IL-4 are two cytokines critical for monocyte 
differentiation into DC. Conventional DC can be further divided into migratory conventional 
DC (migratory cDC) and lymphoid-tissue-resident conventional DC. Typical migratory cDC 
include Langerhans cells and dermal DC in the skin. Thymic DC and splenic DC are 
examples of lymphoid-tissue-resident DC. All DC that are not normally present in steady 
state while appear upon inflammatory or infection are called inflammatory DC. They can be 
differentiated from inflammatory monocytes. 
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Figure 2.  Dendritic cells Subsets. 
Adapted from Shortman K. and Naik S. H., Nature Reviews Immunology 7 (2007) 19-30  
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CHAPTER TWO. Limited Phenotypic and Functional Maturation of 
Bovine Monocyte Derived Dendritic Cells Following Mycobacterium avium 
subspecies paratuberculosis Infection in vitro 
An article published in Veterinary Immunology and Immunopathology1 
Liying Lei 2,3 and Jesse M. Hostetter 2,3 
Abstract 
After encountering antigen, dendritic cells (DC) must differentiate into a fully mature 
phenotype to induce a protective, lasting T cell immunity. Paratuberculosis is a disease 
caused by the intracellular pathogen Mycobacterium avium subspecies paratuberculosis (M. 
paratuberculosis) and is characterized by a transient cell mediated immune response, that 
when dissipates correlates to the onset of clinical disease. In order to study the mechanism of 
early cellular immunity associated with M. paratuberculosis infection, we tested the 
hypothesis that M. paratuberculosis infected bovine DC have impaired activation and 
maturation thus are defective in the initiation of a sustainable and protective Th1 immune 
response locally. Our results demonstrate that M. paratuberculosis infected DC showed 
decreased endocytosis of ovalbumin, indicating some functional maturation. Co-stimulatory 
molecules CD40 and CD80 mRNA expression from M. paratuberculosis infected DC was 
increased over untreated immature DC. M. paratuberculosis infection increased chemokine 
receptor CCR7 in DC, yet CCR5 remained high. MHC II surface expression remained low on 
 
1Reprinted with permission of Vet Immunol Immunopathol. 2007 Dec 15; 120(3-4):177-86. 
Epub 2007 Jun 30. 
2Immunobiology Graduate Program, Iowa State University, Ames, Iowa 
3Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State 
University, Ames, Iowa 
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M. paratuberculosis infected DC. M. paratuberculosis infection inhibited pro-inflammatory 
cytokine IL-12 production and promoted IL-10 secretion by bovine DC. Together, our 
findings showed evidence of phenotypic and functional maturation of DC. However, we did 
not see the expected antigen presentation via MHC II and cytokine responses as a fully 
mature DC. This may suggest semi-mature DC phenotype induced by M. paratuberculosis 
infection. 
Keywords: Mycobacterium avium subspecies paratuberculosis; dendritic cells; maturation 
Introduction 
Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) is an 
intracellular bacillus that causes disease in ruminants characterized by granulomatous 
enteritis and lymphadenitis. It has been shown that the early period after infection is 
associated with cell mediated T-helper cell type 1 (Th1) immune response. However, this 
response is not fully sustained. Development of clinical disease correlates with deterioration 
of cell mediated immunity, which leaves a predominant humoral (Th2) immune response 
(Burrells et al., 1998; Chiodini, 1996). The nature of the early immune response to M. 
paratuberculosis and the exact mechanisms responsible for its decline are unclear.  
Dendritic cells (DC) are the most potent antigen presenting cells, which can induce 
naïve T cell activation and initiate adaptive immune responses. Besides initiation of immune 
response, DC can regulate the immune response by producing pro- and anti-inflammatory 
cytokines (Banchereau et al., 2000; Hope et al., 2003; Howard et al., 2004; Iyonaga et al., 
2002). Immature DC are active antigen capturing cells, while the main function of fully 
mature immunogenic DC is antigen presentation and as a co-stimulatory signal provider. 
CCR5 is expressed on the surface of immature DC and is one of the receptors for chemokine 
macrophage inflammatory protein-1 alpha (MIP-1α). Following interaction with infection 
stimuli, maturing and activated DC decrease expression of CCR5 and up-regulate chemokine 
receptor CCR7 expression. CCR7 receptor mediates migration toward secondary lymphoid 
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organ including regional lymph nodes. Ligands for CCR7 are macrophage inflammatory 
protein-3 beta (MIP-3β) and secondary lymphoid organ chemokine (SLC) (Algood et al., 
2003; Allavena et al., 2000; Pinchuk et al., 2003; Sallusto et al., 2000). CCR5 and CCR7 are 
appropriate markers for DC maturation. Recently, it was reported that there is a third 
maturation status of DC: semi-mature DC or licensed DC phenotype (Lutz and Schuler, 
2002; Martin F. Bachmann1, 2006). Semi-mature DC have undergone phenotypic changes 
consistent with maturation and present antigenic peptide to T cells, however, they lack 
sufficient expression of co-stimulatory molecules and cytokine production to induce T cell 
responses. Moreover, semi-mature DC may induce differentiation and activation of 
regulatory T cells, which may dampen the pre-existing T cell immune response. It has been 
demonstrated that DC at the infection site can be influenced by the bacterial products and 
microenvironment resulting in dysfunctional antigen presentation with incomplete co-
stimulation signals to antigen-specific T cells (Howard et al., 2004).  
Mycobacterium tuberculosis (M. tuberculosis) has been shown to inhibit full 
maturation of human monocyte-derived DC (MDDC) (Hanekom et al., 2003). Virulent M. 
tuberculosis infected human DC had limited and reversible up-regulation of maturation 
markers, such as CD40, CD80, and CD83. M. tuberculosis infected DC induced low level 
allogeneic lymphocyte proliferation and memory CD4+ and CD8+ T cells activation, 
compared to in vitro matured DC. Still, the exact mechanisms by which mycobacterium 
influence DC function and host immunity are not clear. 
With continued understanding of the role of murine and human DC in the 
pathogenesis of infectious diseases, interest in DC from additional species including bovine, 
equine, canine, and porcine DC is growing. Bovine MDDC have been shown to exhibit a 
similar phenotype as human and murine DC (Bajer et al., 2003; Pinchuk et al., 2003; Renjifo 
et al., 1997), and their full characterization continues. The interaction between M. 
paratuberculosis and bovine DC is not fully understood. The objective of the current study 
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was to characterize the interaction between M. paratuberculosis and bovine DC. Our 
hypothesis was that bovine DC are permissive to infection with M. paratuberculosis, and that 
full activation and maturation of M. paratuberculosis infected bovine DC is impaired. In 
order to test this hypothesis, first, we characterized phenotype and function of bovine 
peripheral blood MDDC in our system. Second, the ability of M. paratuberculosis to infect 
MDDC was determined. Third, the interaction of M. paratuberculosis with bovine DC was 
evaluated by phenotypic and functional analysis.  
In this study we show that M. paratuberculosis infects bovine MDDC. Infected DC 
had evidence of phenotypic and functional maturation in terms of surface marker expression, 
co-stimulatory molecule gene transcription, however cytokine production did not favor pro-
inflammatory response and antigen presentation activity is not as high as expected. This 
suggests that M. paratuberculosis infection induces DC maturation, but that the resultant 
phenotype is similar to a semi-mature DC phenotype.  
Materials and Methods 
2.1. Animals. Three-years-old Holstein cows were used in the studies and were housed in 
isolation in Iowa State University Research Farm. Total of four animals were used for this 
study and two at a time. These animals are maintained free of M. paratuberculosis infection 
and are checked by serum ELISA for anti-M. paratuberculosis antibodies and fecal culture 
regularly. All live animal-related protocols in this study were approved by Committee on 
Animal Care and Use at Iowa State University.  
2.2. Generation of bovine peripheral blood monocyte-derived dendritic cell 
(MDDC).  Bovine MDDC were obtained as described elsewhere (Hope et al., 2003; 
Langelaar et al., 2005b; Werling et al., 1999). Briefly, PBMC were isolated by density 
gradient centrifugation on Histopaque (1.083 g/ml, Sigma). PBMC were collected from the 
interphase, and labeled with mouse anti-bovine CD14 mAb (IgG1, MM61A, VMRD) and rat 
anti-mouse IgG1 magnetic microbeads (Miltenyi Biotec). CD14+ cells were positively 
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selected using auto magnetic cell sorting (AutoMACS) separation column (Miltenyi Biotec), 
which were above 90% pure as confirmed by flow cytometry. CD14+ monocytes were 
resuspended to 8×105 cells per ml in RPMI 1640 medium supplemented with 10% FBS, 
0.5mM 2-mercaptoethanol, penicillin G (100 U/ml), streptomycin (100 μg/ml), amphotericin 
B (250 ng/ml), 2mM L-glutamine (complete medium). To generate MDDC, 10 ng/ml 
recombinant human (rh) GM-CSF (PeproTech), 10 ng/ml rh IL-4 (PeproTech) and 5 ng/ml rh 
Flt3-ligand (R&D Systems) were added into complete medium. CD14+ monocytes were 
cultured in a 37ºC, 5% CO2 incubator for 7 days. Half of the medium were replaced by fresh 
medium containing cytokines at Day 4. 
2.3. Bacterium and infection. The M. paratuberculosis strain 19698 was obtained from 
the American Type Culture Collection (Manassas, VA) and maintained in Middlebrook 7H9 
broth supplemented with mycobactin J. To prepare aliquots for in vitro infection, bacteria 
were washed and resuspended in sterile saline. The concentration of bacteria was determined 
by measuring absorbance at 540nm and comparing the absorbance OD value against the 
standard curve. Heat-killed (HK) M. paratuberculosis was prepared by incubating M. 
paratuberculosis in 80°C water bath for 30 minutes. MDDC were infected for 4hrs at 
multiplicity of infection (MOI) 20:1 at 37°C. MOI 20:1 and 4hours infection were based on 
high infectivity and cell viability. As a measure of MDDC infection rate, M. paratuberculosis 
were labeled with FITC prior to infection, and percentage of DC with FITC-conjugated M. 
paratuberculosis intracellularlly was estimated by flow cytometry and fluorescence 
microscopy.  
2.4. Maturation of bovine DC. Following 7 days of culture, bovine MDDC were plated 
in 24-well plate (Costar) in complete medium supplemented with 1 g/ml E. coli 
lipopolysaccharide (LPS, Sigma) for 24hrs.  
2.5. Antibodies, reagents and flow cytometry. Expression level of selected surface 
markers on MDDC was measured using flow cytometry (FACScan, Becton Dickinson). DC 
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were incubated with relevant mAb: anti-bovine CD14 (M-M8), CD1b (TH97A), CD11c 
(BAQ153A), CD172a (CC149), CD205 (CC98), MHC I (H58A), and MHC II (TH81A5), 
which had been diluted in FACS buffer (PBS containing 1% BSA and 0.05% sodium azide). 
All of these antibodies were obtained from VMRD, except that anti-bovine CD172a and 
CD205 were from Serotec. Isotype controls used within the study were MOPC-31C (IgG1), 
MPC-11 (IgG2b), G155-178 (IgG2a), and G155-228 (IgM) (BD Pharmingen). Isotype 
control antibodies were used at the same concentration as the antibody of interest. Cells were 
then labeled with FITC conjugated anti-IgG or PE conjugated anti-IgM secondary antibodies 
(BD Pharmingen). Labeled cells were fixed in 2% paraformaldehyde and analyzed via Flow 
Cytometry. Gates were set on the basis of forward- and side-scatter profiles. Data were 
collected and analyzed using CellQuest software (BD Bioscience) and FlowJo software (Tree 
Star, Inc.).  
2.6. DQ-Ovalbumin (DQ-OVA) endocytosis assay. PH insensitive BODIPY-
conjugated DQ-OVA (Invitrogen) is a self-quenched conjugate of ovalbumin that exhibits 
bright green fluorescence upon proteolytic degradation and can be measured by flow 
cytometry. Treated DC were resuspended at 5×104 per 100ul complete medium. DQ-OVA 
was added to 100ul cell suspension at a concentration of 10 g/ml. Cells were either placed on 
ice or were incubated at 37°C for 1 hour. Controls include 4°C with or without DQ-OVA and 
37°C without DQ-OVA. At the end of incubation period, cells were washed with FACS 
buffer and evaluated immediately via flow cytometry.  
2.7. Lymphocyte proliferation induced by Staphylococcal Enterotoxin B (SEB). 
DC (infected or untreated immature) were added into 96-well round-bottom plate. 
Homogenous lymphocytes were isolated from PBMC based on failure to adhere to plastic 
flasks. PKH67 green fluorescent cell linker (PKH67, Sigma) labeled lymphocytes were 
added into each well at a ratio of 1 DC to 10 lymphocytes. SEB was also added to culture at 
2.5 μg/ml concentration. Lymphocytes cultured with medium or ConA (Sigma) were 
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included as negative and positive controls. Cells were kept in 37ºC, 5% CO2 incubator for 7 
days.  
At day7, lymphocytes were stained with anti-bovine CD3 mAb (MM1A, VMRD). 
The density of PKH67 fluorescence on live, CD3+ T cells was measured by Flow Cytometry. 
Data were collected and analyzed using CellQuest and ModFit LT software (Verity Software 
House). 
2.8. Enzyme-linked immunosorbent assay (ELISA). 8 μg/ml mouse anti-bovine IL-12 
mAb (CC301, Serotec) was added into 96-well flat bottom high binding plate (COSTAR) as 
capture antibody. The plate was blocked with 1% BSA blocking solution (Kirkegaard & 
Perry Laboratories Inc., KPL). Test samples were then added and incubated for 1hour at 
room temperature. After thorough wash, 0.5 μg/ml biotinylated anti-bovine IL-12 mAb 
(CC326, Serotec) was used as detection antibody. This was followed by Streptavidin 
Horseradish Peroxidase (HRP) conjugate (Zymed, Invitrogen) and ABTS peroxidase 
substrate system (KPL). IL-10 ELISA was performed similarly to IL-12 ELISA above, 
except that 5 μg/ml anti-bovine IL-10 mAb (CC318, Serotec) and 2 μg/ml biotinylated anti-
bovine IL-10 mAb (CC320, Serotec) were used as capture antibody and detection antibody 
separately. All concentrations mentioned above were determined by checkerboard 
optimization.  
2.9. Quantitative real time reverse transcriptase polymerase chain reaction 
(qRT-PCR). Total RNA was extracted from treated MDDC using RNeasy mini kit 
(QIAGEN Inc.). Genomic DNA contamination was eliminated using Turbo DNA-free 
(Ambion, Inc.). SuperScript™ III First-Strand Synthesis System for RT-PCR (Invitrogen) 
was used for cDNA synthesis. Two-step real time PCR was performed using SYBR® Green 
PCR system (Applied Biosystems) and detected by a GeneAmp 5700 Sequence Detection 
System. Table 1 lists primer sequences designed by Primer Express Software (Applied 
Biosystems) and GenBank accession numbers. 
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Relative quantification of target gene mRNA was analyzed using modified Pfaffel 
Method (Muller et al., 2002; Pfaffl, 2001). β-actin was used as the internal control, reference 
gene. N0: original copy number.  
N0 target / N0 reference = (1+Efficiency reference) Ct reference / (1+Efficiency target) Ct target 
2.10. Statistical analysis. Data are presented as mean value ± SEM except where stated 
otherwise. JMP 6 statistical analysis software (SAS Institute Inc.) and GraphPad Prism 4.0 
(GraphPad Software Inc.) were used in statistical analysis. Student’s t test was used to 
determine statistical difference between two differentially treated samples. For a group of 
differentially treated samples from several animals, data were analyzed using model fitting in 
JMP software. Two-way analysis of variance with interaction model was used for most 
analysis. Differences were considered significant if p < 0.05.  
Results 
3.1. Morphology, phenotype, and function of bovine DC. Since different culture 
methods and time influence bovine DC phenotype, we first characterized bovine DC by 
morphology and phenotype in our culture system. The MDDC morphology by transmission 
electron micrograph is consistent with that described for MDDC from other ruminants, 
human, mouse, and pig (Bodnar et al., 2001; Fach et al., 2006; Grassi et al., 1998; Langelaar 
et al., 2005a; Paillot et al., 2001). As shown in Fig. 1A, the clearest phenotypic indicator of 
bovine DC was low CD14, moderate to high levels of MHC II, MHC I, CD11c, CD172a, and 
CD1b. Consistent with other reports (Gliddon et al., 2004), CD205 expression was low on 
bovine MDDC, while high on DC isolated from lymph node (data not shown).  
We measured MDDC endocytic potential with and without LPS stimulation. As 
shown in Fig. 1B, 87.8% immature bovine DC were DQ-OVA positive with a marked 
reduction to 38.5% in DQ-OVA uptake by the LPS treated DC. Allostimulatory capacity was 
measured using a mixed lymphocyte reaction. Bovine DC induced significantly higher 
allogeneic T lymphocyte proliferation suggesting stronger antigen presentation ability than 
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macrophages (data not shown). Taken together, these data suggest that the DC generated in 
our culture system have the characteristic morphology, phenotype, and function as MDDC in 
the bovine and other species including mouse and human.   
3.2. Effect of M. paratuberculosis infection on DC phenotype. To determine if bovine 
DC can be infected with M. paratuberculosis, we incubated DC in vitro with non-opsonized 
M. paratuberculosis for 4 hours. Consistent with other reports on M. paratuberculosis 
infected macrophage (Bannantine and Stabel, 2002), M. paratuberculosis was located in the 
DC within a membrane bound vesicle by EM, characteristic of pathogenic mycobacteria. In 
this system we previously determined that the infection rate is typically 50%, using DC 
uptake of FITC conjugated bacteria.  
To evaluate M. paratuberculosis infected dendritic cell maturation, we compared        
surface marker expression between uninfected and M. paratuberculosis infected DC 24 hours 
post infection. Infection status did not significantly influence DC surface expression of MHC 
I, CD1b, CD11c, and DEC205 (data not shown). As shown in Fig. 2, live M. 
paratuberculosis infection did not increase MHC II surface expression compared to untreated 
immature DC.  
We evaluated mRNA level of co-stimulatory molecules CD40, CD80 and chemokine 
receptors CCR5, CCR7 as indicators of maturation and migration capabilities via quantitative 
real time RT-PCR.  RNA isolation was performed on DC 24 hours post infection. M. 
paratuberculosis infected DC had increased CD40 mRNA compared to immature DC (p < 
0.001), and live M. paratuberculosis induced higher increase than heat-killed bacteria (Fig. 
3). CD80 transcription was increased in live M. paratuberculosis infected DC (p < 0.001). As 
shown in Fig. 4, M. paratuberculosis infection in DC did not down-regulate CCR5 
transcription at the time of measurement, yet it tended to induce an increase in the CCR5 
mRNA level. Live M. paratuberculosis infection caused significant increase in CCR7 
mRNA. Based on these data infected DC increase co-stimulatory molecule expression and 
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receptors for lymph node chemotactic signals. It is plausible that M. paratuberculosis 
infected DC have the ability to migrate toward lymph nodes in vivo, thus may interact with T 
cells in lymph nodes.  
3.3. Function of DC infected with M. paratuberculosis. To determine if M. 
paratuberculosis interferes with DC function, we first assayed the ability of infected DC to 
take up DQ-OVA through receptor-mediated endocytosis. As shown in Fig. 5, immature DC 
showed high endocytic function, which was lost after infection with M. paratuberculosis.  
Lymphocyte activation and proliferation induced by M. paratuberculosis infected DC 
was similar to that induced by uninfected DC using mixed lymphocyte reaction (MLR) assay 
(data not shown). Since MLR is mediated via both MHC I and MHC II, we used 
superantigen staphylococcal enterotoxin B (SEB) assay to test specifically MHC II 
expression and the capabilities of M. paratuberculosis infected DC to induce T cell activation 
and proliferation through MHC II antigen presentation (Petersson et al., 2004). Live M. 
paratuberculosis infected DC failed to induce T cell proliferation beyond that of immature 
DC (Fig. 6).  
The ability of infected DC to stimulate adaptive immune responses was measured by 
cytokines IL-12 and IL-10 ELISA. Measurements were taken 24hrs post-infection (Fig. 7). 
IL-12 protein level in culture supernatant of live M. paratuberculosis infected DC was 
similar to immature DC. DC infected with live M. paratuberculosis produced higher amount 
of IL-10 over immature DC (P < 0.01). These data suggest that live M. paratuberculosis 
infection significantly stimulated autocrine IL-10 secretion. 
Discussion 
As the DC is very likely an early cell type to encounter M. paratuberculosis at 
infection sites, we set out to characterize the interaction between DC and M. 
paratuberculosis. The results from this study show that many aspects of phenotypic and 
functional maturation are achieved, but expected increases in MHCII, IL-12 production, and 
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T cell proliferation were not demonstrated. This is consistent with a semi-mature phenotype 
and diminished DC function after infection.  
The bovine DC generated in this study have the predicted morphology, phenotype 
and function for a monocyte-derived DC, and are permissive to infection with M. 
paratuberculosis. In our system, a pattern of low CD14 expression combined with positive 
CD11c, CD172a, and MHC II surface expression were surface markers indicative of bovine 
DC differentiation. We determined that M. paratuberculosis can infect bovine DC which was 
expected based on previous reports on M. tuberculosis and M. avium infecting human and 
murine DC. These data compliment recent reports by Langelaar et. al. that bovine DC are 
responsive to M. paratuberculosis heat shock protein 70 (Langelaar et al., 2005a; Langelaar 
et al., 2005b). Taken together, these data demonstrate a likely role for DC in the pathogenesis 
of M. paratuberculosis infection.  
Failure of DC infected with M. paratuberculosis to attain the features of full 
maturation is consistent with these antigen presenting cells existing in a semi-mature state.  
M. paratuberculosis infected bovine DC did significantly increase expression of CD40, and 
CCR7, and led to diminished endocytic ability. These findings suggest that phenotypically 
and functionally there is initial maturation of DC after infection. However, their ability to 
induce T cell proliferation was low. SEB induced proliferation by cross-linking MHC II on 
DC and TCR was similar to MLR results, indicating low level MHC II mediated antigen 
presentation, and this is consistent with MHC II surface expression on infected DC. The 
cytokine profiles of M. paratuberculosis infected DC also supports these observations with 
relatively high IL-10 and low IL-12 production (Demangel et al., 2002). Considering these 
data it is plausible that M. paratuberculosis infected DC would not drive a strong Th1 
response needed to control/eliminate the infection. 
To the best of our knowledge this is the first study to look at chemokine receptor 
expression on bovine DC infected with M. paratuberculosis. It is plausible that infected, 
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incompletely matured DC, with low MHC II and IL-10 secretion, could migrate to the lymph 
node and induce a tolerogenic effect on T cell immunity. Without proper second and third 
signal, partially matured DC can induce differentiation and activation of tolerogenic T cell or 
regulatory T cell (Hawiger et al., 2001; Steinman et al., 2003). Recent findings of increased 
number of CD4+CD25+ regulatory T cells in the ileum of naturally infected animals at 
clinical stage support the hypothesis of possible regulatory and inhibitory roles of M. 
paratuberculosis infected DC (Weiss et al., 2006).  
In conclusion, we showed that M. paratuberculosis can infect bovine DC. M. 
paratuberculosis infection does not induce strong DC antigen presentation via MHC II and 
full maturation. Also, M. paratuberculosis infected bovine DC have low production of 
cytokine IL-12, but increased IL-10 production. This is significant because the imbalance of 
pro-inflammaotry IL-12, IFN-γ, and anti-inflammatory IL-10 may inhibit not only DC 
maturation, initiation or sustained Th1 polarization, but also bystander macrophages 
activation at infection site.  
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Figure 1. (A). Flow Cytometry analysis of surface markers expression on monocyte-derived 
DC. Mean fluorescence intensity (MFI) is labeled on the plots. Four animals with four 
replications of each animal were done. Histograms of representative animal are shown. 
Isotype control is in black, sample in grey. Immature DC expresses low CD14, moderate to 
high levels of MHC II, MHC I, CD11c, CD172a, and CD1b. (B). Receptor-mediated 
endocytosis of DQ-ovalbumin (DQ-OVA). Immature or LPS treated DC were incubated with 
DQ-OVA for 1 hour at 4°C (grey) or 37°C (black). Fluorescence of intracellular DQ-OVA 
was measured by Flow Cytometry and representative of two animals is shown in this figure. 
Markers were set to measure the percentage of fluorescence positive cells.  
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Figure 2. MHC II expression on M. paratuberculosis infected DC. Live M. paratuberculosis 
infected DC did not show increase in MHC II expression as expected (p=0.11). MHC II 
positive DC were gated based on isotype control in each experiment and %gated cells are 
shown. Data are four replicates of two animals. iDC: immature DC; HK: heat-killed. 
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Figure 3. CD40 and CD80 mRNA levels in treated bovine DC measured by quantitative real 
time RT-PCR. DC were treated as labeled in the figure. (A) M. paratuberculosis infected DC 
showed increased CD40 mRNA over untreated DC. (B) CD80 mRNA was increased in live 
M. paratuberculosis infected DC. *** was used to show p < 0.001. CD40 and CD80 genes 
expression were normalized to beta-actin in each treatment. Bars are relative gene expression 
level with SEM of four replicates from two animals. 
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Figure 4. Effects of M. paratuberculosis infection on bovine DC chemokine receptors 
expression. M. paratuberculosis infection alone had no effect on CCR5 mRNA level in DC. 
Live M. paratuberculosis infected DC had 27 fold higher CCR7 mRNA than iDC. Bars are 
fold change relative to iDC controls with SEM. iDC: immature DC. Data are from two 
animals with four replications each. * shows p < 0.05.  
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Figure 5. Effect of M. paratuberculosis infection on DQ-OVA endocytosis by DC. DC were 
incubated with DQ-OVA at either 37°C or 4°C. Data are expressed as delta mean 
fluorescence intensity (MFI) values, which represents 37°C MFI values minus 4°C values. 
Immature DC endocytosed more DQ-OVA than M. paratuberculosis infected DC as shown 
by statistical analysis (*** P < 0.001). Delta MFI ± SEM are shown. Data are replications 
from two animals.  iDC: immature DC; HK: heat-killed. 
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Figure 6. Lymphocyte proliferation induced by staphylococcal enterotoxin B (SEB) and DC. 
DC were untreated or infected with M. paratuberculosis before incubated with homogenous 
T lymphocytes and SEB. Live M. paratuberculosis infected DC induced low T cell 
proliferation, which is consistent with low MHC II surface expression. Mean of proliferation 
index normalized to lymphocyte alone control ± SEM (two animals with three replications 
from each) are shown in the figure. * shows p < 0.05 
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Figure 7. Live M. paratuberculosis infection inhibited IL-12 production by infected DC, but 
promoted IL-10 secretion. Data in figures are pooled data from two animals with three 
replicates each. IL-12 production by live M. paratuberculosis infected DC was 4.4 fold lower 
than LPS activated DC (*** P < 0.01). Meanwhile, live M. paratuberculosis infection 
induced significantly higher IL-10 production by infected DC over iDC (*** P < 0.01). 
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APPENDIX.  Additional Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Figure 1. Morphology of bovine monocyte-derived DC. Transmission electron micrograph of 
a monocyte-derived DC after 7 days of culture. Note: DC showed characteristic dendritic 
processes around the periphery of the cell and numerous intracellular membrane bound 
vesicles. Magnification= 10,100X. 
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Figure 2. M. paratuberculosis infection of DC. DC were infected with live M. 
paratuberculosis and prepared for transmission electronic microscopy analysis. Arrow 
indicates the intracellular M. paratuberculosis. Magnification = 10,100X.  
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CHAPTER THREE. Phenotypic and Functional Features of CD11c+ 
Dendritic Cell-Like Cells in Granulomatous Lesion Induced by 
Mycobacterium avium subspecies paratuberculosis  
An article to be submitted to Clinical and Vaccine Immunology 
Liying Lei 1,2, Brandon L. Plattner 2, and Jesse M. Hostetter 1,2 
Abstract 
In this study, the cellular influx, cytokine environment, also phenotype and function 
of dendritic cells within Mycobacterium avium subspecies paratuberculosis (M. 
paratuberculosis) induced granulomatous lesions were investigated. Naïve 4-6 weeks old 
calves were used in the in vivo infection model system and were infected with live M. 
paratuberculosis whole bacteria subcutaneously on the neck. Calves in the control group 
were injected with M. paratuberculosis vaccine subcutaneously on the neck. Seven days 
post-inoculation, palpable lesions at injection sites were present and were removed 
surgically. Total granuloma cells were isolated from the granulomatous lesion and labeled 
with antibodies specific for dendritic cell (DC, CD11c+ CD205+), macrophage (CD14+ 
CD68+), CD4+ T cell, CD8+ T cell, and B cell. CD11c+ cells were isolated from total 
granuloma cells and analyzed for surface marker expression, cytokine gene expression, and 
the ability to induce antigen-specific CD4+ T cell proliferation and cytokine production. Our 
results demonstrate that cell composition was different between M. paratuberculosis and 
vaccine induced granulomas. Specifically there were fewer CD11c+ CD205+ DC-like cells,  
macrophages, and CD4+ T cells within M. paratuberculosis induced granulomatous lesions. 
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Most of these CD4+ T cells also expressed marker CD25. Compared to the cells in the 
vaccine granuloma, cells in M. paratuberculosis induced granuloma had low levels of gene 
expression for interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), transforming growth 
factor-β (TGF-β), and IL-4. CD11c+ DC-like cells within both M. paratuberculosis and 
vaccine induced granulomas showed medium levels of MHC I and MHC II surface 
expression, and were negative for CD14 surface expression. M. paratuberculosis granuloma 
CD11c+ cells had low costimulatory molecules CD40, CD80, CD86, chemokine receptor 7 
(CCR7), cytokines IL-12 p40 and IL-10 gene expression when compared with vaccine 
granuloma CD11c+ cells. The ability of CD11c+ DC-like cells recovered from M. 
paratuberculosis granuloma to induce antigen-specific CD4+ T cell proliferation was lower 
than that of vaccine granuloma DC. Overall IL-10, IL-12, IFN-γ, and IL-4 production was 
low by cells in the M. paratuberculosis granuloma DC-lymphocyte co-cultures. These 
observations suggest that M. paratuberculosis-induced granulomas have different cellular 
composition and cytokine environment as vaccine induced granulomas. CD11c+ DC-like 
cells are present in lower numbers and have an incomplete maturation phenotype within M. 
paratuberculosis induced granuloma. These CD11c+ cells induce antigen-specific CD4 T cell 
response while providing poor co-stimulation and cytokine signals. These results add to our 
understanding of the early immune response following M. paratuberculosis infection.  
Key words: M. paratuberculosis, dendritic cell, granuloma, vaccine. 
Introduction 
M. paratuberculosis is a Gram-positive intracellular pathogenic bacillus, which 
causes granulomatous enteritis and lymphadenitis in wild and domestic ruminants (Harris 
and Barletta, 2001). M. paratuberculosis infection causes significant economic loss each year 
worldwide and is a public health concern (Chamberlin et al., 2001; Naser et al., 2002). The 
host immune response of M. paratuberculosis infection is under intensive study. 
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In the natural infection model, early subclinical period of M. paratuberculosis 
infection is suggested to be a Th1 (T helper cell type 1) cell mediated immune response, 
which is followed by a dominant Th2 response during the clinical phases of infection. While 
the exact mechanisms of the early cellular immune response and diminish of this Th1 
response are still under study, CD4+ T cells, CD8+ T cells, and γδ T cells have been shown to 
be the key mediators in this response (Stabel, 2000b). Considering that T lymphocytes 
receive the antigenic information from antigen-presenting cells (APCs, macrophage, 
dendritic cell, and B cell) and their functions are regulated by APCs, APCs may also be 
critical in shaping and maintaining the immune response towards M. paratuberculosis 
infection after their initial encounter with the bacteria. In addition to antigen presentation, 
dendritic cells (DC) also have the active regulatory function on existing immune responses 
by secreting pro- and anti-inflammatory cytokines (Banchereau et al., 2000; Howard et al., 
2004; Iyonaga et al., 2002). Phenotype, function, and maturation status of DC affect the type 
of immune responses they generate. 
Granuloma formation is the characteristic lesion that develops during mycobacterial 
and other intracellular pathogens infection (Chiu et al., 2004; Hagge et al., 2004; Saunders 
and Britton, 2007). The organization of and the cells involved in the formation of 
granulomatous lesions vary with the types of pathogens that cause the infection. Briefly, 
granulomatous lesions are often categorized into two forms, both of which have the 
infiltration of macrophages and lymphocytes. Type one (tuberculoid) granuloma has the 
classic, well-organized granuloma structure with epitheloid and multi-nucleated giant cells in 
the center surrounded by lymphocytes and fibrous tissue, in some cases a necrotic center. It 
gets the name since M. tuberculosis generally induces the formation of type one granulomas.  
Cytokine TNF-α has been shown to be critical in the formation of tuberculoid granuloma 
(Lin et al., 2007). Type two (lepromatous) granuloma is characterized by the loosely-
organized granuloma, with wide-spread macrophages heavily burdened with acid-fast 
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microorganisms, very few giant cells and lymphocytes. M. paratuberculosis infection often 
results in this type of diffuse lepromatous granuloma. It is now known that granuloma 
morphology is influenced by the balance between Th1 and Th2 responses and alterations in 
Th1/Th2 type cytokine secretion (Tanaka et al., 2005).  
The recruitment of waves of immune cells to an infection site is driven by an array of 
cytokines and chemokines produced by multiple cell types, including infected macrophages 
and DC. TNF-α is an extensively studied cytokine in granuloma formation and appears to be 
the most important cytokine in the maintainance of granuloma structure (Bean et al., 1999; 
Flynn et al., 1995; Lin et al., 2007; Russell, 2007). It was shown that TNF-/- single gene 
knockout mice infected with M. tuberculosis succumbed to infection, with widespread 
dissemination of M. tuberculosis.  Instead of forming localized granulomas containing 
activated macrophages and T cells, cellular infiltrates in TNF-/- mice were poorly organized 
(Bean et al., 1999; Lin et al., 2007). This study and other reports indicate a significant role of 
TNF-α in the organization of granulomas. Besides infected macrophages, dendritic cells are 
also producers of TNF-α during intracellular pathogen infection (Serbina et al., 2003; Tam 
and Wick, 2004). TNF-α acts as a positive feedback signal on infected DC and macrophage 
to secret more TNF-α, chemokines CCL2 (monocyte chemotactic protein-1, MCP-1) and 
CXCL10, IL-1, and IL-18. These cytokines and chemokines drive the infiltration of CD4+ T 
cells, CD8+ T cells, monocytes, neutrophils, and natural killer (NK) cells (Algood et al., 
2003). Recruited immune cells produce cytokines and chemokines that amplify the cascade 
of cell infiltration to infection site and formation of granuloma (Flynn and Chan, 2005; 
Ulrichs and Kaufmann, 2006). Interestingly, the regulation of this cascade and control of cell 
recruitment require IFN-γ as a negative feedback. IFN-γ gene disrupted mice were unable to 
shut down this response and had disseminated tuberculosis and tissue damage (Cooper et al., 
1993). Tuberculosis reactivation has occurred subsequent to anti-TNF therapy (Infliximab 
and Adalimumab) in the patients with rheumatoid arthritis, Crohn’s disease, and psoriasis 
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(Ehlers, 2005; Hueber and McInnes, 2007; Lin et al., 2007; Plessner et al., 2007). These anti-
TNF treated patients often have extrapulmonary or disseminated tuberculosis. These 
observations confirm the essential role of TNF-α in maintaining granuloma structure and 
controlling M. tuberculosis infection. Since M. paratuberculosis induce a loosely organized 
and diffuse granuloma, the role of TNF-α in M. paratuberculosis infection is of great interest.   
Although T lymphocytes have been known to be involved in the development and 
formation of granuloma, it was not until recently that dendritic cells, as the most important 
inducer of T cell response, were shown to be present in the granulomatous lesions induced 
experimentally by beads, M. bovis Bacillus Calmette-Guerin (BCG) or M. tuberculosis, and 
play a role in the initiation and regulation of granulomatous inflammation (Chiu et al., 2004; 
Iyonaga et al., 2002; Tsuchiya et al., 2002). Foamy cells within the lung granulomas of mice 
infected with M. tuberculosis expressed characteristic DC markers CD205, MHC II, CD11c, 
and CD40 at high levels (Ordway et al., 2005). DC accumulated at the periphery of the BCG 
induced pulmonary granulomas. It was shown that DC in granulomatous lung lesions 
expressed high levels of MHC II, CD80, CD86 and had potent capacity to induce PPD-
specific T lymphocyte proliferation (Tsuchiya et al., 2002). A study using PPD-coated beads 
induced granuloma showed that DC recruited under inflammatory conditions favor a Th1-
biased immune response (Chiu et al., 2004). Alternative mechanisms are required for Th2 
commitment. Under Th1-predominant inflammatory conditions, immature myeloid DC 
produce IL-23 and directly induce the formation of granuloma (Mizoguchi et al., 2007). All 
of these studies suggest that dendritic cells may play a critical role in the formation and 
organization of the loosely-structured granulomatous lesions in M. paratuberculosis 
infection.  
Semi-mature DC can present antigenic peptides to T cells but lack the proper 
costimulation signals, thus induce an aberrant downstream T cell response and possible 
generation of regulatory T cells (Lutz and Schuler, 2002; Martin F. Bachmann1, 2006).  We 
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showed in a previous report that M. paratuberculosis infection results in semi-mature DC 
differentiation in an in vitro system (Lei and Hostetter, 2007). The goal of the current study is 
to determine the phenotype, function, and maturation of DC in M. paratuberculosis infection 
in vivo. Our hypothesis is that DC infiltrate into M. paratuberculosis induced granulomatous 
lesions and undergo incomplete maturation, and therefore, are unable to induce a sustained 
protective Th1 immune response.  
In order to test this hypothesis, we used the localized M. paratuberculosis 
subcutaneous infection model system developed by Simutis et al. with modifications (Simutis 
et al., 2005). Using this system, dendritic cells at the inoculation site can be readily obtained 
for phenotypic and functional assays. We first determined the cellular composition and 
cytokine profile within live M. paratuberculosis induced granulomatous lesions. Secondly, 
CD11c+ cells were isolated by magnetic cell separation from fresh tissue or were recovered 
from to the fluorescence labeled frozen granulomatous lesions using LCM (laser capture 
microdissection). Isolated CD11c+ cells were analyzed for surface marker expression, 
costimulatory molecules and chemokine receptor gene expression, and a panel of cytokines 
associated with granulomatous inflammation. Finally, the ability of M. paratuberculosis 
granuloma CD11c+ cells to induce antigen specific CD4+ T lymphocyte proliferation and 
cytokine production was determined.  
In this study we demonstrated that live M. paratuberculosis induced the formation of 
a disorganized granulomatous lesion at the subcutaneous injection site. Compared to vaccine 
induced lesion, M. paratuberculosis induced granuloma contained fewer DC, macrophages, 
and CD4 T cells. The M. paratuberculosis granuloma cells expressed intermediate levels of 
IFN-γ, and low TNF-α, TGF-β, and IL-4.  M. paratuberculosis granuloma CD11c+ cells had 
medium levels of MHC I and MHC II surface expression, and induced antigen-specific CD4 
T cell proliferation, which suggest that these CD11c+ cells obtained some aspects of mature 
DC phenotype. However, M. paratuberculosis granuloma CD11c+ cells had low co-
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stimulatory molecules and CCR7 gene expression, and produced low levels of pro- and anti-
inflammatory cytokines, which are consistent with incomplete DC maturation.   
Materials and Methods 
Animals. 4-6 weeks old Holstein calves were used in the following experiments and were 
housed in isolation in Iowa State University College of Veterinary Medicine biosafety level 
II animal care facility during the study. A total of six animals were used for this project and 
three at a time for handling purposes. These animals were maintained free of infection other 
than the inoculum given in the study. All live animal-related protocols were approved by 
Committee on Animal Care and Use at Iowa State University.  
Bacterial inoculum and infection. The M. paratuberculosis 19698 strain was obtained 
from the American Type Culture Collection (Manassas, VA) and maintained in Middlebrook 
7H9 broth supplemented with mycobactin J. Log-phase growing live M. paratuberculosis 
were washed and resuspended in sterile saline for the use of in vivo infection. The 
concentration of bacteria was determined by measuring absorbance at 540nm and comparing 
the absorbance OD value against the standard curve as described previously (Chiodini and 
Buergelt, 1993). The viability of M. paratuberculosis inoculum used in these studies were 
shown to be above 90% viable as checked via Fluorescein Diacetate (FDA) stain and flow 
cytometry analysis (Jayapal et al., 1991; Simutis et al., 2007). The purity of the inoculum was 
also confirmed before use. Two animals were given an injection of 5x108 CFU (colony 
forming units) live M. paratuberculosis subcutaneously on the neck at Day 0.  
Vaccine. M. paratuberculosis vaccine (Mycopar®) from Fort Dodge Animal Health was 
used as a control. Mycopar is a whole cell bacterin containing inactivated M. 
paratuberculosis bacteria. Mycopar generates a granuloma in vivo and was used as a control 
of well-organized granuloma. Four animals were injected 0.25 ml (half dose) of the M. 
paratuberculosis vaccine subcutaneously on the neck at Day 0.  
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Granuloma cell isolation. Palpable lesions were present at both live M. paratuberculosis 
and M. paratuberculosis vaccine injection sites seven days post inoculation, and were 
removed surgically for analysis. Lesions were frozen in liquid nitrogen, or fixed with 
formalin, or transported fresh in cold RPMI 1640 medium for cell isolation.  
Granuloma cells were isolated by mincing granulomatous tissue and digesting with 
0.25% Type IV-S collagenase (from Clostridium histolyticum, Sigma) in complete medium 
for 30 minutes at 37ºC on a shaker. Complete medium is prepared by adding 10% fetal 
bovine serum (FBS), 0.5mM 2-mercaptoethanol, penicillin G (100 U/ml), streptomycin (100 
μg/ml), amphotericin B (250 ng/ml), 2mM L-glutamine to RPMI 1640 medium. Collagenase 
treatment was followed by gentle homogenization to completely release cells from 
granuloma. Granuloma single cell suspension was washed and counted. 106 to 108 cells with 
more than 90% cell viability were the typical yield from single granuloma in our hands. Total 
granuloma cells were then divided into groups for cell composition analysis and for CD11c+ 
cells separation. 
Peripheral blood mononuclear cell (PBMC) lymphocyte isolation. PBMC were 
isolated by density gradient centrifugation on Histopaque (1.083 g/ml, Sigma) and were 
collected from the interphase. In order to isolate lymphocytes to be used in the proliferation 
assays, total PBMC were plated overnight in tissue culture flasks in complete medium to 
allow plastic adherence of monocytes. Non-adherent lymphocytes were washed off from the 
flasks with PBS and collected on the second day.  
Antibodies, reagents and flow cytometry. Granuloma cells were incubated with 
relevant mAb: anti-bovine CD11c (BAQ153A, VMRD), CD205 (CC98, Serotec), CD14 (M-
M8, VMRD), B cell (B-B4, BAQ155A, VMRD), CD4 (CACT138A, VMRD), CD8-β 
(BAT82A, VMRD), CD25 (IL-2 receptor alpha, CACT116A, VMRD), MHC I (H58A, 
VMRD), MHC II (TH81A5, VMRD), and anti-human CD68 (EBM11, Dako), which had 
been diluted in FACS buffer (PBS containing 1% BSA and 0.05% sodium azide). Proper 
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isotype controls were used at the same concentration as the antibody of interest in the study, 
including MOPC-31C (IgG1), MPC-11 (IgG2b), G155-178 (IgG2a), and G155-228 (IgM) 
(BD Pharmingen). Cells were then labeled with FITC (Fluorescein isothiocyanate) 
conjugated anti-IgG (Invitrogen), or PE (Phycoerythrin) conjugated anti-IgG (Invitrogen), or 
PE conjugated anti-IgM secondary antibodies (BD Pharmingen). Labeled cells were fixed in 
2% paraformaldehyde and analyzed via flow cytometry. Gates were set based on the 
forward- and side-scatter profiles. Data were collected and analyzed using CellQuest (BD 
Bioscience) and FlowJo software (Tree Star, Inc.).  
Histology, immunohistochemistry, and lesion scoring. Granulomatous lesion sections 
were stained with hematoxylin and eosin (H&E) or reserved for immunohistochemistry 
(IHC) stain for CD4, CD68, and CD11c. Frozen tissue sections were fixed in either cold 
acetone (CD11c), or cold ethanol (CD4). Formalin fixed granuloma lesions were used for the 
CD68 stain. Mouse anti-bovine CD4 (IL-A11, VMRD), mouse anti-bovine CD11c 
(BAQ153A, VMRD), and mouse anti-human CD68 (EBM11, Dako) were used as primary 
antibodies respectively. Secondary antibodies include biotinylated goat anti-mouse IgG and 
anti-mouse IgM mAbs. This incubation is followed by streptavidin-HRP (horseradish 
peroxidase, Zymed), substrate DAB, and color development.  
H&E stained granulomatous lesions were individually scored using a scoring system 
adapted from previous publications (Hostetter et al., 2005; Johnson et al., 2006; Wangoo et 
al., 2005). Briefly, scores of 0-3 were assigned for individual parameters to reflect the degree 
and organization of that particular parameter within the lesion. A score of 0 indicates that the 
parameter was absent from the lesion while a score of 3 indicates a high degree of 
organization of the parameter in any given lesion. The following parameters were included: 
mature fibrous connective tissue, macrophages, lymphocytes, multi-nucleated giant cells, 
necrosis, and mineralization. Individual parameters were summated and a single collective 
score was assigned for each lesion, which reflected the histological organization or stage of 
 83
development of individual lesions. Saline control site were included as a negative control and 
were devoid of significant inflammation.  
CD11c+ DC-like cell isolation. Total granuloma cells were labeled with anti-bovine 
CD11c mAb (IgM), and followed by anti-IgM magnetic beads. CD11c+ cells were positively 
selected using auto magnetic cell sorting (AutoMACS) separation column (Miltenyi Biotec). 
The purity of CD11c+ cells isolated by this method was above 90% as confirmed by flow 
cytometry. 
Laser capture microdissection (LCM) of immunofluorescence stained frozen 
tissue. Frozen granulomatous lesion was cut at 6μm and immunofluoresence labeled for 
CD11c. Alexa Fluor 488 anti-mouse IgM (A21042, Invitrogen) was used as secondary 
antibody for this purpose. Green fluorescence positive CD11c cells were captured via LCM 
and used for RNA isolation. For total granuloma cells isolation, frozen tissue was cut and all 
of the immune cells inside granulomatous lesion were captured using LCM. Total RNA from 
either CD11c+ cells or total granuloma cells was extracted using PicoPureTM RNA isolation 
kit (Molecular Devices). The quantity and quality of the RNA were determined by 
NanoDrop® ND-1000.  
Quantitative real time reverse transcriptase polymerase chain reaction (qRT-
PCR). Possible genomic DNA contamination in the RNA samples was eliminated using 
Turbo DNA-free (Ambion). SuperScript™ III First-Strand Synthesis System for RT-PCR 
(Invitrogen) was used for cDNA synthesis. SYBR® Green PCR system (Applied 
Biosystems) was used in the two-step real time PCR and the signal was detected by a 
GeneAmp 5700 Sequence Detection System. Primer sequences designed by Primer Express 
Software (Applied Biosystems) and GenBank accession numbers are listed in Table 1. 
Relative quantification of target gene mRNA was analyzed using the equation below, 
modified based on the Pfaffle method (Muller et al., 2002; Pfaffl, 2001). β-actin was used as 
the internal control, reference gene. N0: original copy number.  
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N0 target / N0 reference = (1+Efficiency reference) Ct reference / (1+Efficiency target) Ct target 
PPD (Purified Protein Derivatives) antigen specific CD4+ T lymphocyte 
proliferation induced by granuloma CD11c+ cells. Isolated CD11c+ cells from either 
vaccine or M. paratuberculosis induced granulomas were incubated in medium containing 
10μg/ml PPD for overnight. PPD pulsed granuloma CD11c+ cells were then added into 96-
well round-bottom plate. Lymphocytes were separated from total peripheral blood 
mononuclear cells (PBMC) based on failure to adhere to plastic surface. Lymphocytes were 
labeled with PKH67 green fluorescent cell linker (PKH67, Sigma) and added into the plate at 
a ratio of 1 CD11c+ cell to 10 lymphocytes. CD11c+ cells and lymphocytes from the same 
animal were cultured together. As for negative and positive controls, labeled lymphocytes 
were cultured in medium alone or medium containing Concanavalin A (ConA, Sigma). Cells 
were kept in 37ºC, 5% CO2 incubator for 7 days.  
At day 7, lymphocytes were collected and stained with anti-bovine CD4 mAb 
(CACT138A, VMRD). Proliferation of these CD4+ T cells was analyzed by measuring the 
density of PKH67 fluorescence on the live CD4+ T cells via flow cytometry. Number of 
CD4+ T cells in the culture was determined by comparing with the known number of 
polystyrene latex microsphere (5μm, Invitrogen) added into the cell suspension. Data were 
collected and processed using CellQuest and Modfit LT software (Verity Software House). 
Intracellular cytokine staining. PKH67 labeled peripheral blood lymphocytes that had 
been co-cultured with PPD treated CD11c+ cells for 7 days were harvested and stained for 
intracellular cytokines production. Lymphocytes were fixed with 2% paraformaldehyde for 
20 minutes and permeabilized with PermaWash buffer (PBS containing 0.1% saponin and 
0.1% sodium azide) for 10 minutes. For IFN-γ staining, permeabilized lymphocytes were 
incubated with mouse anti-bovine IFN-γ mAb (7B6, IgG1, AbD Serotec) and followed by PE 
conjugated anti-IgG secondary antibody (Invitrogen). For intracellular IL-4 staining, PE 
conjugated mouse anti-bovine IL-4 mAb (CC303, IgG2a, AbD Serotec) was used for the 
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direct labeling. Proper isotype controls were included in the assay. Labeled lymphocytes 
were then fixed again with 2% paraformaldehyde, washed, and analyzed via flow cytometry.  
Enzyme-linked immunosorbent assay (ELISA). Supernatant of lymphocytes and 
granuloma CD11c+ cells co-culture was collected and analyzed for secretion of cytokines 
IFN-γ, IL-12, and IL-10 by ELISA. BOVIGAMTM (Bovine IFN-γ Test) kit (CSL Veterinary) 
was used for detection of IFN-γ protein in the supernatant. Recombinant IFN-γ protein (AbD 
Serotec) was used as positive control to generate the standard curve. IL-12 and IL-10 ELISA 
were done following the protocols in the previous report (Lei and Hostetter, 2007). Briefly, 
mouse anti-bovine IL-12 mAb (CC301) 8μg/ml was used as capture antibody to coat plate. 
After blocking with 1% BSA (bovine serum albumin), test samples and controls were added. 
0.5μg/ml biotinylated mouse anti-bovine IL-12 mAb (CC326) was used as detection 
antibody. For IL-10 ELISA, 5μg/ml mouse anti-bovine IL-10 mAb (CC318) and 2μg/ml 
biotinylated mouse anti-bovine IL-10 mAb (CC320) were used as capture and detection 
antibody respectively. Supernatant of LPS treated monocyte-derived DC and LPS activated 
macrophage was used as controls for IL-12 and IL-10 assays respectively. All of these 
antibodies were obtained from AbD Serotec.  
Statistical analysis. Data are presented as mean value ± SEM (standard error mean) except 
where stated otherwise. Software used for statistical analysis and scientific graph generating 
include JMP 7 (SAS Institute Inc.) and GraphPad Prism 4.0 (GraphPad Software Inc.). 
Student’s t test and ANOVA (analysis of variance) test were used for the statistical analysis. 
Differences were considered significant if p < 0.05.  
Results 
Immune cell infiltration and cellular composition are different in M. 
paratuberculosis and vaccine induced granulomatous lesions. Palpable, firm nodules 
formed at both vaccine and M. paratuberculosis injection sites 7 days post inoculation, and 
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were removed surgically for analysis. Histology of granulomatous lesions induced by M. 
paratuberculosis or vaccine is shown in Figure 1A. Morphologically, diffuse granulomatous 
inflammation that lacks organization was seen at the M. paratuberculosis inoculation site, 
while diffuse granulomatous inflammation with some degree of organization presented at the 
vaccination site. Individual nodules were beginning to form at the vaccination site and were 
separated by fibrous tissue. Well-organized granulomatous lesion was seen at vaccine 
injection site at later time point (data not shown). Lesions were scored based on individual 
parameters, including fibrous tissue, macrophages, and lymphocytes. Individual parameters 
were summated and the collective score for each lesion is shown in Figure 1B. M. 
paratuberculosis inoculation site lesions scored lower than the vaccination site, suggesting 
lower degree of organization. Some individual parameters scored significantly lower in M. 
paratuberculosis lesions (fibrous tissue).   
In order to analyze the cellular composition in M. paratuberculosis induced 
granuloma, total granuloma cells were isolated and phenotype was determined via flow 
cytometry based on surface marker expression. Compared to the vaccine granuloma, there 
were significantly less CD11c+ CD205+ cells (DC-like cells), CD14+ CD68+ cells 
(macrophages), and CD4+ T lymphocytes present in the M. paratuberculosis induced 
granuloma (p < 0.05, Figure 2A). Most of the CD4+ T cells in the lesion also expressed 
marker CD25 on the cell surface (data not shown). As shown in Figure 2B, the M. 
paratuberculosis induced granuloma contained fewer CD4+ CD25+ T cells compared to the 
vaccine granuloma (p < 0.05). The presence and the number of CD11c+ cells, macrophages, 
and CD4+ T cells were further confirmed by IHC stain (Figure 2C). The staining frequency 
for these cells correlated with the percentages determined by flow cytometry.  
Cytokine gene expression in M. paratuberculosis and vaccine granuloma cells. To 
better understand the microenvironment within the granuloma, we used laser capture 
microdissection to directly recover granuloma cells from in vivo generated lesions. Cells 
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recovered from M. paratuberculosis induced granulomatous lesions expressed significantly 
lower levels of IFN-γ, TNF-α and TGF-β than the cells in vaccine induced granuloma (p < 
0.05, Figure 3). Both M. paratuberculosis and vaccine granuloma cells had low IL-4 
expression. All data were normalized to the internal control β-actin, which was expressed at 
comparable level inside both tissues.  
Phenotypic features of CD11c+ cells in granulomatous lesion induced by M. 
paratuberculosis. To explore the role of antigen presenting cells within the granuloma, we 
recovered CD11c+ cells using magnetic cell separation on granuloma digests. CD11c+ cells 
were checked for surface markers associated with bovine dendritic cells. As shown in Figure 
4, granuloma CD11c+ cells expressed low level of CD14 and medium to high levels of MHC 
I and MHC II molecule, which were independent on the inoculation status. These cells were 
also positive for CD205 expression (data not shown). This pattern of surface marker 
expression is consistent with previous reports on bovine DC (Langelaar et al., 2005a; Lei and 
Hostetter, 2007) and DC phenotype in other species (Bodnar et al., 2001; Fach et al., 2006; 
Paillot et al., 2001).  
To further analyze the maturation of granuloma CD11c+ cells, the gene expression of 
costimulatory molecules (CD40, CD80, and CD86) and chemokine receptor (CCR7) was 
determined via real time RT-PCR. Granulomatous cryosections were labeled 
immunofluorescently for marker CD11c, and CD11c+ cells were captured from granuloma 
sections based on fluorescence by LCM. Compared to the vaccine granuloma DC, M. 
paratuberculosis granuloma CD11c+ DC-like cells had significantly lower CD40, CD80, 
CD86, and CCR7 gene expression, which is consistent with limited maturation (Figure 5A).  
Function of M. paratuberculosis induced granuloma CD11c+ DC-like cells. 
Cytokine production and the ability to induce CD4+ T cell proliferation by granuloma 
CD11c+ cells were evaluated. Gene expression in M. paratuberculosis granuloma CD11c+ 
cells showed less IL-10 and IL-12 p40 subunit expression than vaccine granuloma CD11c+ 
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cells; also there was a trend of lower IL-12 p35 subunit and IL-18 level in these cells (Figure 
5B).  
To analyze the capacity of granuloma DC to promote T cell proliferation, we 
measured peripheral blood T cells antigen-specific proliferation induced by granuloma 
CD11c+ cells. There were similar amount of CD4+ T cells in the peripheral blood of 
vaccinated and M. paratuberculosis inoculated animals. ConA treated lymphocytes from 
both groups of animals proliferated equally well (data not shown). Lymphocytes cultured in 
medium containing PPD were included as a control, and these cells proliferated at very low 
level. 47.7% lymphocytes cultured with vaccine granuloma CD11c+ cells were CD4+ 
PKH67dim, which consist of proliferated CD4+ T cells (Figure 6A). However, only 26.5% of 
the lymphocytes in culture were CD4+ PKH67dim cells after stimulation with the M. 
paratuberculosis granuloma DC. The difference between the two treatments is significant 
when data from six animals were combined (Figure 6B). Proliferation data were also 
analyzed using ModFit software. The proliferation index of M. paratuberculosis granuloma 
DC co-culture is slightly lower than vaccine granuloma DC treatment (Figure 6C). Lower 
percentage of lymphocytes in M. paratuberculosis granuloma DC co-cultures proliferated 
more than five generations. Despite addition of equal numbers of CD4+ T cells to CD11c+ 
cells cultures, the total number of CD4+ T cells in M. paratuberculosis granuloma DC co-
cultures was slightly lower than the vaccine granuloma DC co-cultures (Figure 6D).  
Cytokine production by lymphocytes co-cultured with granuloma CD11c+ cell was 
analyzed by cytokine intracellular staining and supernatant ELISA. 18% of lymphocytes co-
cultured with vaccine granuloma DC were IL-4 intracellularly stain positive, which were also 
PKH67dim proliferated cells (Figure 7A). In contrast, M. paratuberculosis granuloma CD11c+ 
cells did not induce IL-4 production. The amount of IFN-γ producing lymphocytes was 
similar in both vaccine and M. paratuberculosis granuloma DC treatments (Figure 7B). No 
difference in the MFI (mean fluorescence intensity) of IFN-γ stained lymphocytes was 
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observed in lymphocyte-granuloma DC co-cultures (Figure 7C). However, MFI of IFN-γ in 
M. paratuberculosis inoculated animal peripheral blood lymphocytes was higher than that in 
vaccinated animal lymphocytes.  
The level of secreted cytokines in the culture supernatant was determined by ELISA. 
Peripheral blood lymphocytes from vaccinated or M. paratuberculosis inoculated animals 
secreted similar amount of IFN-γ when cultured in medium alone or with ConA (Figure 8A). 
Peripheral blood lymphocytes produced significantly higher level of IFN-γ when cultured 
with vaccine granuloma DC than the lymphocytes cultured with M. paratuberculosis 
granuloma DC (p < 0.05). Vaccine granuloma DC-lymphocyte co-culture contained higher 
level of IL-10 protein (Figure 8B). Granuloma DC from both groups produced limited 
amount of IL-12 (Figure 8C).  
Discussion 
In the present study, we used a subcutaneous infection model and evaluated the local 
immune response at the M. paratuberculosis inoculation sites, specifically the phenotype and 
function of the CD11c+ DC-like cells within the lesions. We found that M. paratuberculosis-
induced granulomatous lesions contained fewer CD11c+ CD205+ cells, macrophages, and 
CD4+ T cells compared to vaccine granulomas. M. paratuberculosis granuloma cells 
produced low levels of pro-inflammatory and regulatory cytokines which are all critical in 
regulating the immune response and granuloma structure formation. CD11c+ cells within M. 
paratuberculosis granuloma expressed MHC I and MHC II and induced antigen-specific 
CD4 T lymphocyte proliferation, which suggest some phenotypic and functional maturation 
of these DC. However, M. paratuberculosis granuloma CD11c+ cells failed to provide strong 
costimulation and proper cytokine signals to T cells. As a result, proliferated T cells 
produced low IL-4 and IFN-γ. Taken together, these data suggest that CD11c+ cells within M. 
paratuberculosis granuloma undergo limited and incomplete maturation in vivo. 
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The finding of significantly lower numbers of CD4+ T lymphocytes in M. 
paratuberculosis induced granulomatous lesions together with the loose-organization of 
these granulomas support previous immunohistochemistry studies that naturally infected 
sheep had higher densities of CD4+ T cells in the ileal tissue with tuberculoid well-organized 
granulomatous lesions and a decrease in CD4+ T cells associated with loosely organized 
lepromatous lesions and advance of the disease (Little et al., 1996; Navarro et al., 1998). 
Most CD4 T cells in M. paratuberculosis induced granuloma expressed CD25 marker, so M. 
paratuberculosis induced granuloma contained fewer CD4+ CD25+ T cells. Further research 
needs to be done to determine whether these CD4+ CD25+ T cells have regulatory function in 
vivo. Our hypothesis is that this CD4+ CD25+ population contains both regulatory and 
activated CD4 T cells.  
M. paratuberculosis granulomas had a relatively low IFN-γ, TGF-β, IL-4, and TNF-α 
cytokine environment. Because of the effects of TNF-α on the cascade secretion of other 
cytokines and chemokines, subsequent immune cell infiltration, and organization of the 
lesion, low TNF-α gene expression at early time in M. paratuberculosis induced granuloma 
may provide an explanation for the lack of structure and diffuse of immune cells at the 
infection site. Indeed, cells within vaccine granuloma produced high IFN-γ, TGF-β, IL-4, and 
TNF-α. High pro-inflammatory cytokine load may explain the better organized and more 
intense granulomatous lesions observed in vaccinated animals. High TNF-α gene expression 
associates with the tuberculoid form of granulomas seen in vaccinated animals at later time 
point. We showed that vaccine granuloma CD11c+ cells had high IL-10 production at both 
gene expression and protein level. We consider the high TGF-β, IL-4, and IL-10 expression 
in vaccine granuloma to be a host feedback control mechanism in response to the inactivated 
M. paratuberculosis vaccine and the attempt to restrain the extensive inflammation.  
M. paratuberculosis granuloma contained significantly less dendritic cells than 
vaccine granuloma. CD11c+ cells in M. paratuberculosis granuloma were positive for MHC I 
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and MHC II surface expression and were able to induce antigen-specific CD4 T lymphocytes 
proliferation. At the same time these CD11c+ cells were found to be low in CD40, CD80, 
CD86, and CCR7 expression, which may suggest incomplete maturation. Dendritic cells 
recruited to the infection site were shown to be actively trafficking into and out of the 
granuloma (Iyonaga et al., 2002). It is also possible that CD11c+ cell isolated from M. 
paratuberculosis granuloma contained a mixture of pathogen-encountered maturing DC and 
newly recruited immature DC, which may lead to the relatively low expression of co-
stimulatory molecules and CCR7 we observed.  The recruitment of immature DC to the 
inoculation site and the migration of maturing DC to the draining lymph node may occur at 
both M. paratuberculosis and vaccine induced granulomas, but at a different efficiency. 
Generally, DC in vaccine granuloma had a higher co-stimulatory molecules and CCR7 gene 
expression. Since the dendritic cell trafficking or migration to draining lymph node and 
antigen presentation to T cells determine the outcome of the mycobacterial infection (Marino 
et al., 2004), it is of great interest to study the trafficking of DC into and out of M. 
paratuberculosis granulomas in future research. A good vaccine for M. paratuberculosis 
should optimally induce a quick DC turnover at the infection site, while promoting DC 
activation and maturation for antigen presentation to T lymphocytes and cytokine production.  
In this study, peripheral blood lymphocytes were used as the source of responder T 
cells in the proliferation assay. We consider most of the T lymphocytes in peripheral blood at 
7 days post inoculation to be naïve and effector T cells. CD11c+ cells isolated from M. 
paratuberculosis or vaccine granulomas induced homogeneous peripheral blood CD4 T 
lymphocytes proliferation. In both groups, most of the CD4+ T cells proliferated as all CD4+ 
T cells present in the PKH67dim quadrant, suggesting CD11c+ cells from both M. 
paratuberculosis granuloma and vaccine granuloma possessed the ability to induce CD4+ T 
lymphocyte proliferation. Vaccine granuloma DC had a slightly higher capacity as a CD4 T 
cell proliferation inducer, since the CD4 T cells proliferated more generations as higher 
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percentage of cells showed in later generations (generation 4-6) on the ModFit analysis and 
more CD4+ cells had dimmer PKH67 on the flow cytometry dot plot. Besides a relatively 
lower ability of M. paratuberculosis granuloma CD11c+ cells to induce CD4 T cell 
proliferation, the fact that the total number and percentage of CD4+ T cells in the M. 
paratuberculosis granuloma CD11c+ cells with lymphocyte treatment were lower may also 
associate with some T cell death. TUNEL stain (terminal deoxynucleotidyl transferase 
(TdT)-mediated dUTP nick end labeling) needs to be done to evaluate the presence and 
degree of cell death within the M. paratuberculosis granulomatous lesions. Although 
costimulatory molecules may not be as important in effector and memory T cell proliferation 
as in naïve T cell proliferation, signal between CD28 on T cell and CD80, CD86 on dendritic 
cell is shown to be critical to prevent T cell death (Collette et al., 1998; Noel et al., 1996). 
Thus, the CD4 T cell death may relate to the low costimulatory molecules expression on the 
M. paratuberculosis granuloma DC we observed. Low TGF-β gene expression in M. 
paratuberculosis granuloma may also play a role in the T cell death, since TGF-β has also 
been show to prevent activated T cell death (Golstein and Wyllie, 2001). Further studies are 
required to completely elucidate the possible mechanisms involved.  
CD11c+ cells isolated from M. paratuberculosis granuloma expressed lower levels of 
IL-10, IL-12 p40, IL-12 p35, and IL-18 than the cells from vaccine granuloma. Low IL-12 
protein level was confirmed by ELISA. Heterodimeric cytokines IL-12 and IL-23 share 
subunit IL-12p40, and IL-12 also uses IL-12p35 subunit while IL-23 uses IL-12p19 subunit 
(Cooper et al., 2002). IL-12, IL-23, and IL-18 are all inducers of IFN-γ production. As a 
result, M. paratuberculosis granuloma CD11c+ cells may have a lower ability to produce IL-
23, IL-12, and IL-18, which ties into the low IFN-γ in the live M. paratuberculosis 
granuloma microenvironment, low percentage of IFN-γ producing cells, and low IFN-γ 
protein in the supernatant of the lymphocytes with M. paratuberculosis granuloma DC co-
culture. Surprisingly, IFN-γ intracellular stain of peripheral blood lymphocytes from M. 
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paratuberculosis inoculated animals showed higher IFN-γ density than vaccinated animal 
lymphocytes. This difference was still present after the lymphocytes were treated with ConA. 
The percentages of IFN-γ producing lymphocytes were similar between two groups. The 
difference between the percentage and MFI data may be due to readily and quicker release of 
IFN-γ from vaccinated animal peripheral blood lymphocytes at the time we did the 
intracellular staining, while M. paratuberculosis infected animal peripheral blood 
lymphocytes had a slower IFN-γ release. There is also possibility that M. paratuberculosis 
infection induces lymphocytes IFN-γ production by but may interfere with the release or 
secretion of IFN-γ from the lymphocytes into surrounding environment. The multidrug 
resistance P-glycoprotein (P-gp) as drug transporter is also actively involved in the 
transmembrane flux of cytokines in normal peripheral blood T lymphocytes, including IL-2, 
IL-4, and IFN-γ (Drach et al., 1996). P-gp inhibitors inhibit efflux or release of IFN-γ and IL-
2. It is possible that M. paratuberculosis produces or induces the production of P-gp 
inhibitor, or causes the reduction of P-gp expression, thus interferes with the IFN-γ release 
from T lymphocytes. Further research needs to be done to test this hypothesis.  
In summary, M. paratuberculosis and vaccine granulomas have a different cell 
composition and distribution. M. paratuberculosis granuloma has a lower IFN-γ, TGF-β, and 
TNF-α cytokine environment. M. paratuberculosis granuloma CD11c+ DC-like cells have 
the characteristic semi-mature DC phenotype and function with medium levels of MHC I and 
MHC II molecule expression, low costimulatory molecule and CCR7 expression, and low 
levels of pro- and anti-inflammatory cytokines production. M. paratuberculosis granuloma 
DC induce CD4 T lymphocyte antigen specific proliferation, yet these proliferated T cells 
produce low level IFN-γ and IL-4.  
To our knowledge, this is the first report to study systemically the cellular 
composition and relative contribution of each cell type to the formation of the loosely 
organized M. paratuberculosis granuloma by flow cytometry. Also, M. paratuberculosis 
 94
induced granuloma was compared side by side with vaccine induced granuloma, which is 
known to be able to induce the formation of the typical tuberculoid well-organized 
granuloma. For the first time, the phenotypic and functional features of CD11c+ DC-like cells 
in M. paratuberculosis infection were analyzed in an in vivo system. These data will provide 
critical information to the research of M. paratuberculosis pathogenesis, control of the 
disease, and future vaccine development. 
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Figure 1. Histology of granulomatous lesions induced by M. paratuberculosis or vaccine 7 
days post inoculation. (A). Morphologically, M. paratuberculosis inoculation site (left) 
showed diffuse granulomatous inflammation that lacks organization, while diffuse 
granulomatous inflammation with some degree of organization presented at the vaccination 
site (right). Individual nodules were beginning to form and were separated by fibrous tissue 
at vaccination site (right). Magnification 10X. Representative images from two M. 
paratuberculosis inoculated animals and four vaccinated animals are shown. (B). Lesions 
were scored from 0 to 3 based on individual parameters to reflect the degree and organization 
of that particular parameter within the lesion. Collective scores of individual parameters for 
each lesion are shown in the figure. The overall score for M. paratuberculosis lesions is 
lower than vaccination site, although not statistically significant (P = 0.08). Pooled data from 
two M. paratuberculosis inoculated animals and four vaccinated animals are shown in the 
graph.  
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Figure 2. Cellular composition is different in M. paratuberculosis or vaccine induced 
granulomas at Day7. (A). There were fewer CD11c+ CD205+ cells, macrophages, CD4+ T 
cells in M. paratuberculosis induced granulomas compared to vaccine granulomas. p < 0.05 
is labeled with * on the graph. 105 granuloma cells were labeled with mAbs to each of the 
markers shown in the figure and were analyzed via flow cytometry. (B). M. paratuberculosis 
induced granulomas contained fewer CD4+ CD25+ T lymphocytes compared to vaccine 
induced granulomas (p < 0.05). Pooled data from two M. paratuberculosis inoculated 
animals and four vaccinated animals are shown in the graph. (C). Granulomatous lesions 
were immunohistochemically stained for CD4, CD11c, and CD68. The staining frequency 
correlates to the percentage of these cells determined by flow cytometry. Arrows in figure 
indicate cells stained positive for the specific markers. Representative images from six 
animals are shown. Magnification 40X. Bar in the graph represents 50μm. 
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Figure 3. Cytokine gene expression in total granuloma cells at either M. paratuberculosis or 
vaccine inoculation site at Day7. Cells in M. paratuberculosis induced granulomas had 
significantly lower levels of IFN-γ, TGF-β, and TNF-α gene expression than the cells in 
vaccine granulomas. IL-4 mRNA level was low in both M. paratuberculosis and vaccine 
granuloma. β-actin was used as internal control for assay and was expressed at similar level 
in both tissues. Target gene mRNA expression was normalized to β-actin mRNA within the 
same tissue. p < 0.05 is considered to be statistical significant and labeled with * on the 
graph. Data were generated from two M. paratuberculosis inoculated animals and four 
vaccinated animals. 
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Figure 4. Surface marker expression on CD11c+ DC-like cells recovered from M. 
paratuberculosis (M.a.ptb.) or vaccine induced granulomas. Cells from both tissues 
expressed low to negative level CD14, which is consistent with low CD14 level on bovine 
monocyte-derived DC. CD11c+ cells from both M. paratuberculosis and vaccine induced 
granulomas expressed medium levels of MHC I and MHC II. Isotype control is in red, 
sample in green. Flow cytometry plots are representatives of two M. paratuberculosis 
inoculated animals and four vaccinated animals. 
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Figure 5. Granuloma CD11c+ DC-like cells co-stimulatory molecule, chemokine receptor, 
and cytokine gene expression determined via realtime RT-PCR. Immunofluoresence-labeled 
CD11c+ cells were isolated from frozen granulomatous lesions by laser capture 
microdissection. (A) The enriched population of CD11c+ cells in M. paratuberculosis 
induced granuloma had significantly lower CCR7, and co-stimulatory molecules CD40 and 
CD80 gene expression than the cells in vaccine granuloma. (B) Production of anti-
inflammatory cytokine IL-10 and pro-inflammatory cytokines IL-12 p35 and IL-12 p40, IL-
18 tended to be lower in M. paratuberculosis induce granuloma DC than the cells in vaccine 
induced granuloma. β-actin was used as internal control for the assay and was expressed at 
similar level in both tissues. Target gene mRNA expression was normalized to β-actin 
mRNA within the same tissue. p < 0.05 is considered to be statistical significant and labeled 
with * on the graph. Data are from two M. paratuberculosis inoculated animals and four 
vaccinated animals. 
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Figure 6. Granuloma CD11c+ DC-like cells induced CD4+ T lymphocytes proliferation. 
CD11c+ cells were isolated from M. paratuberculosis or vaccine granulomas and pulsed with 
PPD for overnight. Lymphocytes were isolated from peripheral blood of the same animal, 
from which the DC were recovered. (A). Lymphocytes cultured in medium barely 
proliferated. 47.7% of total T lymphocytes cultured with vaccine granuloma DC were 
PKH67dim CD4+, which are proliferated CD4+ T cells, while there was only 26.48% 
PKH67dim CD4+ T cells in M. paratuberculosis granuloma DC-lymphocyte co-culture. 
Lymphocytes were cultured alone in medium containing PPD as a control, and these cells 
proliferated at very low level. (B). There were significantly fewer PKH67dim CD4+ T cells in 
M. paratuberculosis granuloma DC plus lymphocyte culture than vaccine DC co-culture 
(P<0.05). Lymphocytes used in both groups proliferated at similar level upon ConA 
stimulation. (C). Proliferation index (PI) of vaccine DC treatment was higher than M. 
paratuberculosis DC treatment, with higher numbers of lymphocytes proliferated more 
generations. Percentage of lymphocytes at each proliferation generation is shown in the 
figure. (D). The number of PKH67dim CD4+ cells in M. paratuberculosis granuloma DC plus 
lymphocyte culture was lower compared to vaccine DC co-culture. Data are from two M. 
paratuberculosis inoculated animals and four vaccinated animals. 
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Figure 7. Granuloma CD11c+ DC-like cells induced CD4+ T lymphocytes to produce 
inflammatory cytokines. Lymphocytes co-cultured with homogeneous granuloma CD11c+ 
cells were collected and stained for intracellular cytokine production. (A). Lymphocytes 
alone in medium did not produce IL-4. 18.03% of total lymphocytes co-cultured with vaccine 
granuloma DC were PKH67dim IL-4+, which represents IL-4 producing lymphocytes that 
underwent proliferation. This population was absent in M. paratubeculosis granuloma DC 
co-cultures. (B). Approximately 20% of total lymphocytes were IFN-γ producing proliferated 
cells in both M. paratuberculosis and vaccine granuloma DC lymphocyte co-cultures. 
Controls from both groups had similar amount of IFN-γ producing cells. (C). MFI (mean 
fluorescence intensity) of IFN-γ positive cells was similar in both M. paratuberculosis and 
vaccine granuloma DC lymphocyte co-cultures. However, MFI in lymphocytes from M. 
paratuberculosis infected animals cultured in medium alone or with ConA was higher than 
that in vaccinated animals (p < 0.05), suggesting each lymphocyte contained more IFN-γ in 
M. paratuberculosis infected animals. Data are from two M. paratuberculosis inoculated 
animals and four vaccinated animals. 
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Figure 8. Granuloma CD11c+ DC-like cells induced CD4+ T lymphocytes to produce pro-
inflammatory and anti-inflammatory cytokines. Cytokines in the supernatant of lymphocytes 
with homogeneous granuloma CD11c+ cells co-cultures were determined by ELISA. 
Significant lower levels of IFN-γ (A) and IL-10 (B) were present in the M. paratuberculosis 
granuloma DC-lymphocyte co-cultures compared to vaccine granuloma DC co-cultures 
(p<0.05). No difference was seen between two groups when lymphocytes were cultured 
alone in medium or with ConA. (C). Low level IL-12 protein was found to present in all 
treatments. Data are from two M. paratuberculosis inoculated animals and four vaccinated 
animals. 
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CHAPTER FOUR. Phenotype and Function of CD11c+ Dendritic Cell-Like 
Cells in Lymph Node Draining Mycobacterium avium subspecies 
paratuberculosis Induced Granulomatous Lesions from Vaccinated or Non-
vaccinated Calves    
An article to be submitted to Clinical and Vaccine Immunology 
Liying Lei 1,2, Brandon L. Plattner 2, and Jesse M. Hostetter 1,2 
Abstract 
In this study, we evaluated the phenotypic and functional features of the CD11c+ 
dendritic cell (DC)-like cells, cellular composition and the cytokine environment in the 
lymph node draining Mycobacterium avium subspecies paratuberculosis (M. 
paratuberculosis) challenge site. One group of calves was made immune by prior vaccination 
with M. paratuberculosis vaccine followed by M. paratuberculosis challenge. The control 
group was non-vaccinated calves challenged with M. paratuberculosis. Granulomatous 
lesions persisted at the challenge sites in both vaccinated and non-vaccinated animals from 
day 7 till day 60 post inoculation, the conclusion of the study. In vaccinated animals, the 
cervical lymph node draining the challenge site (CLN) appeared to be in an activated state 
with more germinal centers than the CLN in non-vaccinated animals. By flow cytometric 
analysis, greater numbers of CD11c+ CD205+ cells and B cells were present in the vaccinated 
animal CLN. Similar numbers of macrophages, CD4 T cells, CD4+ CD25+ T cells, and CD8 
T cells were present in both vaccinated and non-vaccinated animal CLNs. The CD11c+ cells 
had a mature phenotype with high levels of MHC I, MHC II, and CD205 surface expression.  
 
1Immunobiology Graduate Program, Iowa State University, Ames, Iowa 
2Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State 
University, Ames, Iowa 
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Vaccinated animals CLN CD4+ T lymphocytes proliferated at a significantly higher level 
after stimulation with homogeneous CLN PPD-pulsed CD11c+ cells compared to non-
vaccinated animal lymphocytes. Also, these lymphocytes that underwent proliferation 
produced high levels of IFN-γ and IL-4. Interestingly, non-vaccinated animals CLN CD8+ T 
lymphocytes proliferated at a higher level upon PPD-pulsed CD11c+ cells stimulation. Cells 
in the lymph node draining M. paratuberculosis challenge site produced high levels of 
cytokine IL-12 and IL-10, and which was independent of the prior vaccination status. These 
results suggest that commercial M. paratuberculosis vaccination has effects on DC activation 
and maturation upon M. paratuberculosis challenge. CD4 T cell and CD8 T cell recall 
response and cytokine environment in the lymph node draining M. paratuberculosis 
challenge site are affected by prior vaccination.  
Key words: Mycobacterium paratuberculosis, dendritic cell, CD11c+ cell, innate immunity, 
granuloma, vaccine. 
Introduction 
Early M. paratuberculosis infection is associated with dominant cell mediated T-
helper cell type 1 (Th1) immune response, which is the response essential to control 
infections by intracellular pathogen.  With the progression of the infection, Th1 immune 
response wanes and overlaps with a humoral (Th2) immune response (Jiao et al., 2003; 
Ritacco et al., 1991). Development of clinical disease is generally consider to be associated 
with a dominant Th2 immune response (Burrells et al., 1998; Chiodini, 1996). The nature of 
early immune response to M. paratuberculosis and the exact mechanisms responsible for the 
shift of balance between Th1 and Th2 response are still unclear. In previous studies we found 
that live M. paratuberculosis infection induced limited activation and maturation of dendritic 
cell in both in vitro and in vivo infection systems (Lei and Hostetter, 2007 and data in 
preparation for publication). In this study our goal is to analyze the phenotype and function 
of the CD11c+ DC-like cells in the lymph node draining M. paratuberculosis infection site. 
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Since semi-mature DC can also migrate into draining lymph node and induce the 
differentiation of T cells with a regulatory phenotype, it is of great interest to determine the 
maturation status of these lymph node DC and the type of T cell immune response these DC 
induce. 
With the implementation of the Johne’s disease control programs and the lack of 
treatment options, there is renewed interest in prevention of M. paratuberculosis infection. 
Novel vaccine designs are under development including subunit vaccine and DNA vaccine 
strategies. A more complete understanding of the immune response following vaccination 
will provide valuable information in future vaccine design. We were interested in 
understanding the mechanism of the vaccine in shaping the host immune response, 
specifically the phenotype and function of antigen presenting cells. Mycobacterium bovis 
Bacillus Calmette-Guerin (BCG) vaccination was shown to promote development of IL-10-
producing dendritic cells and IL-10-producing T cells, while inhibiting IL-12 production by 
these monocyte-derived DC (Madura Larsen et al., 2007). BCG vaccination also enhanced 
macrophage activity inside the granulomatous lesions upon Mycobacterium tuberculosis (M. 
tuberculosis) challenge (Ordway et al., 2006). In this study, BCG vaccinated mice had a 
better control of following M. tuberculosis infection with increasing macrophage number and 
lower bacterial load. The goal of the current study was to determine the effects of M. 
paratuberculosis vaccine on the phenotype, function, activation, and maturation of dendritic 
cells upon M. paratuberculosis challenge.  
To achieve this goal, we used the localized M. paratuberculosis subcutaneous 
infection model system developed by Simutis et al. with modifications (Simutis et al., 2005). 
Previous research using this model system demonstrated that focal granulomatous lesions 
developed in response to subcutaneous bacterial challenge and persisted from day 7 untill 
day 60 post inoculation, the conclusion of the study. Using this system, dendritic cells and 
lymphocytes in the lymph node draining M. paratuberculosis inoculation site can be readily 
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obtained for phenotypic and functional assays. CD11c+ cells were isolated by magnetic cell 
isolation and used for functional and phenotypic analyses. We determined the cellular 
composition of the lymph node draining M. paratuberculosis inoculation site, surface marker 
expression on isolated CD11c+ cells, the ability of these cells to induce antigen-specific CD4 
and CD8 T cell proliferation and cytokine production.  
The results of these studies indicate that significantly greater numbers of CD11c+ 
cells were present inside the vaccinated calves lymph node draining M. paratuberculosis 
inoculation site (CLN) than the CLN in non-vaccinated calves. These cells had a mature 
phenotype with high level expression of MHC I, MHC II, and CD205, and high ability to 
induce antigen-specific CD4 T cell proliferation and IFN-γ and IL-4 production. CD8 T cells 
in vaccinated animal CLN proliferated at a lower level upon PPD-pulsed DC stimulation than 
non-vaccinated animal.  
Materials and Methods  
Animals. 4-6 weeks old Holstein calves were used in the following experiments and were 
housed in isolation in Iowa State University College of Veterinary Medicine biosafety level 
II animal care facility during the study. A total of nine calves were used for this project and 
three at a time for handling purpose. These animals were maintained free of infection other 
than the treatments received in the study. All live animal-related protocols were approved by 
Committee on Animal Care and Use at Iowa State University.  
Vaccine. M. paratuberculosis vaccine (Mycopar®) from Fort Dodge Animal Health was 
used for vaccination of calves. Mycopar is a whole cell bacterin containing inactivated M. 
paratuberculosis bacteria suspended in oil. Six animals were given an injection of 0.25 ml 
(half dose) M. paratuberculosis vaccine subcutaneously on the left side of the neck at Day 0. 
Three control animals received equal volume of saline instead at Day 0.  
Bacterial inoculum and infection. The M. paratuberculosis lab-adapted strain 19698 
was obtained from the American Type Culture Collection (Manassas, VA) and maintained in 
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Middlebrook 7H9 broth supplemented with mycobactin J. Log-phase growing live M. 
paratuberculosis were resuspended in sterile saline for the use of in vivo infection. The 
concentration of bacteria was determined as described previously (Chiodini and Buergelt, 
1993) by measuring absorbance at 540nm and comparing the absorbance OD value against 
the standard curve. The viability of M. paratuberculosis inoculum used in these studies was 
shown to be above 90% alive as checked via Fluorescein Diacetate (FDA) stain and flow 
cytometry analysis (Jayapal et al., 1991; Simutis et al., 2007). The purity of the inoculum was 
also checked. All nine animals were injected 5x108 CFU (colony forming units) of live M. 
paratuberculosis subcutaneously on the right side of the neck 60 days post vaccination, both 
vaccinated and non-vaccinated groups.  
Experimental design. Calves were either vaccinated or given saline (control) at the start of 
the study (Day 0) on the left side of the neck. 60 days post vaccination; all vaccinated and 
non-vaccinated animals were challenged subcutaneously on the right side of the neck with 
live M. paratuberculosis. Superficial cervical lymph nodes draining the M. paratuberculosis 
inoculation site were removed aseptically 60 days post M. paratuberculosis inoculation. 
Lymph nodes used for histology were fixed in 10% neutral buffered formalin. Lymph nodes 
used for cell isolation were transported back to laboratory in cold RPMI 1640 medium 
supplemented with 10% fetal bovine serum (FBS), 0.5mM 2-mercaptoethanol, penicillin G 
(100 U/ml), streptomycin (100 µg/ml), amphotericin B (250 ng/ml), 2mM L-glutamine 
(complete medium).  
On the day of excision, lymph nodes were processed to isolate total lymph node cells 
and to be used for further isolation of CD11c+ cells and lymphocytes (described below). 
Total lymph node cells were lysed and plated onto Middlebrook 7H10 agar for CFU (colony 
forming unit) count. Lymph node cells were also stained for selected cell type specific 
markers, including CD4, CD8, CD11c CD205 (DC), CD14 CD68 (macrophage), and B cell, 
to determine the cellular composition. Lymph nodes CD11c+ cells re-stimulated with PPD 
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(purified protein derivatives) were co-cultured with homogeneous lymph node lymphocytes 
for 7 days. Lymphocytes in the culture were then harvested to analyze the antigen-specific 
proliferation and intracellular cytokine production. Culture supernatant was collected to 
determine the cytokine release.   
Peripheral blood was drawn one week before and on the day of lymph node removal. 
Peripheral blood cells were used to generate monocyte-derived dendritic cells (MD-DC) and 
to isolate lymphocytes used as responder cell donor in the proliferation assays.  
Lymph node CD11c+ DC-like cells and lymphocytes isolation. Lymph nodes were 
minced to release the cells. Homogenization of the lymph nodes was also done when 
necessary. Above 90% cell viability can be achieved after the cell isolation in our hands. 
Total lymph node cells were then divided into groups for cellular composition analysis and 
for CD11c+ cells and lymphocytes separation.  
Total lymph node cells were labeled with anti-bovine CD11c mAb (IgM, BAQ153A, 
VMRD), and followed by anti-IgM magnetic beads (Miltenyi Biotec). Labeled CD11c+ cells 
were positively selected using auto magnetic cell sorting (AutoMACS) separation column 
(Miltenyi Biotec). The CD11c+ cells isolated via this method were of above 90% purity as 
confirmed by flow cytometry. In order to recover lymph node lymphocytes, total lymph node 
cells were plated overnight in tissue culture flasks in complete medium to allow cells to 
adhere to the plastic surface. Non-adherent lymphocytes were washed off from the flasks 
with PBS and collected on the second day.  
Peripheral blood monocyte-derived dendritic cell (MD-DC) generation and 
lymphocyte isolation. PBMC were isolated by density gradient centrifugation on 
Histopaque (1.083 g/ml, Sigma) and were collected from the interphase. Peripheral blood 
lymphocytes were separated based on failure to adhere to plastic culture flask surface.  
MD-DC were generated following the protocol as described previously (Hope et al., 
2003; Langelaar et al., 2005b; Lei and Hostetter, 2007; Werling et al., 1999). Briefly, PBMC 
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were labeled with mouse anti-bovine CD14 mAb (IgG1, MM61A, VMRD) and rat anti-
mouse IgG1 magnetic microbeads (Miltenyi Biotec). CD14+ cells were positively selected 
using AutoMACS separation column and cultured in complete medium containing 10ng/ml 
recombinant human (rh) GM-CSF (PeproTech), 10ng/ml rhIL-4 (PeproTech) and 5ng/ml 
rhFlt3-ligand (R&D Systems) for 7 days. Half of the medium were replaced by fresh medium 
containing cytokines at Day 4. 
Antibodies, reagents and flow cytometry. Single cell suspension of total lymph node 
cells was checked for cellular composition and the number of these different types of cells 
via flow cytometry (FACScan, Becton Dickinson). 106 lymph node cells were used for each 
marker staining.  
Lymph node cells were incubated with relevant mAb: anti-bovine CD11c 
(BAQ153A, VMRD), CD205 (CC98, Serotec), CD14 (M-M8, VMRD), B lymphocytes (B-
B4, BAQ155A, VMRD), CD4 (CACT138A, VMRD), CD8-β (BAT82A, VMRD), CD25 
(IL-2 receptor alpha, CACT116A, VMRD), MHC I (H58A, VMRD), MHC II (TH81A5, 
VMRD), and anti-human CD68 (EMB11, Dako), which had been diluted in FACS buffer 
(PBS containing 1% BSA and 0.05% sodium azide). Proper isotype controls were used at the 
same concentration as the antibody of interest in the study, including MOPC-31C (IgG1), 
MPC-11 (IgG2b), G155-178 (IgG2a), and G155-228 (IgM) (BD Pharmingen). Cells were 
then labeled with FITC (Fluorescein isothiocyanate) conjugated anti-IgG (Invitrogen), or PE 
(Phycoerythrin) conjugated anti-IgG (Invitrogen), or PE conjugated anti-IgM secondary 
antibodies (BD Pharmingen). Labeled cells were fixed in 2% paraformaldehyde and analyzed 
via flow cytometry. Gates were set based on the forward- and side-scatter profiles. Data were 
collected and analyzed using CellQuest (BD Bioscience) and FlowJo software (Tree Star, 
Inc.).  
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Histology of lymph nodes draining M. paratuberculosis inoculation sites. M. 
paratuberculosis inoculation site draining lymph nodes were fixed in 10% neutral buffered 
formalin and sections of the tissue were stained with hematoxylin and eosin (H&E).  
PPD-antigen specific T lymphocyte proliferation induced by M. paratuberculosis 
challenge site draining lymph node CD11c+ cells. Isolated CD11c+ cells from M. 
paratuberculosis challenge site draining lymph nodes (CLN) in vaccinated or non-vaccinated 
animals were incubated in medium containing 10μg/ml PPD for overnight. PPD pulsed CLN 
CD11c+ cells were then added into 96-well round-bottom plate. Homogenous lymphocytes 
were separated from same challenge site lymph node. Lymphocytes were labeled with 
PKH67 green fluorescent cell linker (PKH67, Sigma) and added into the plate at a ratio of 1 
CD11c+ cell to 10 lymphocytes. As negative and positive controls, labeled lymphocytes were 
cultured with medium alone or medium containing PPD or Concanavalin A (ConA, Sigma). 
Cells were kept in 37ºC, 5% CO2 incubator for 7 days.  
At day 7, lymphocytes were collected and stained with either anti-bovine CD4 mAb 
(CACT138A) or anti-bovine CD8-β mAb (BAT82A). Proliferation of these T cells was 
analyzed by measuring the density of PKH67 fluorescence on the live CD4+ or CD8+ T cells 
via flow cytometry. Number of CD4+ or CD8+ T cells in the culture was determined by 
comparing with the known number of polystyrene latex microsphere (5μm, Invitrogen) added 
into the cell suspension. Data were collected and processed using CellQuest and Modfit LT 
software (Verity Software House).  
Intracellular cytokine staining. PKH67 labeled CLN lymphocytes that had been co-
cultured with PPD treated CD11c+ cells for 7 days were stained for intracellular cytokines 
production. Lymphocytes were fixed with 2% paraformaldehyde for 20 minutes and 
permeabilized with PermaWash buffer (PBS containing 0.1% saponin and 0.1% sodium 
azide) for 10 minutes. For IFN-γ staining, permeabilized lymphocytes were incubated with 
mouse anti-bovine IFN-γ mAb (7B6, IgG1, AbD Serotec) and followed by PE conjugated 
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anti-IgG secondary antibody (Invitrogen). For intracellular IL-4 staining, PE conjugated 
mouse anti-bovine IL-4 mAb (CC303, IgG2a, AbD Serotec) was used for the direct labeling. 
Proper isotype controls were included in the assay. Labeled lymphocytes were fixed again 
with 2% paraformaldehyde, washed, and analyzed via flow cytometry.  
Enzyme-linked immunosorbent assay (ELISA). Supernatant of CLN lymphocyte-DC 
co-cultures was analyzed for secretion of cytokines IL-12 and IL-10 by ELISA. IL-12 and 
IL-10 ELISA were done following the protocols in the previous report (Lei and Hostetter, 
2007). Briefly, mouse anti-bovine IL-12 mAb (CC301) 8μg/ml was used as capture antibody 
to coat plate. After blocking with 1% BSA (bovine serum albumin), test samples and controls 
were added. 0.5μg/ml biotinylated mouse anti-bovine IL-12 mAb (CC326) was used as 
detection antibody. For IL-10 ELISA, 5μg/ml mouse anti-bovine IL-10 mAb (CC318) and 
2μg/ml biotinylated mouse anti-bovine IL-10 mAb (CC320) were used as capture and 
detection antibody respectively. All of these antibodies were obtained from AbD Serotec.  
Statistical analysis. Data are presented as mean value ± SEM (standard error mean) except 
where stated otherwise. Software used for statistical analysis and scientific graph generating 
include JMP 7 (SAS Institute Inc.) and GraphPad Prism 4.0 (GraphPad Software Inc.). 
Student’s t test and ANOVA (analysis of variance) test were used for the statistical analysis. 
Differences were considered significant if p < 0.05. 
Results 
Cell infiltration and cellular composition in the M. paratuberculosis challenge site 
draining lymph nodes (CLN) from vaccinated or non-vaccinated animals. 60 days 
post M. paratuberculosis inoculation, lymph nodes draining the M. paratuberculosis 
challenge site (CLN) in both vaccinated and non-vaccinated animals were enlarged. 
Histologically, fewer germinal centers were present in the node cortex in CLN from non-
vaccinated animals compared to the CLN from vaccinated animals (Figure 1). Total lymph 
node cells were lysed and plated on 7H10 agar plate. No CFU were recovered from the 
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lymph node draining M. paratuberculosis challenge site after one month culture, which was 
independent of previous vaccination status (data not shown).   
Given the differences identified by histological analysis, we conducted a flow 
cytometric analysis of DC, macrophage, CD4 T cell, CD8 T cell, and B cell populations from 
the two groups following M. paratuberculosis challenge. Total lymph node cells were 
labeled with selected cell type specific markers to determine the cellular composition inside 
the draining lymph node 60 days post inoculation. As shown in Figure 2A, CLN from both 
groups contained large numbers of B cells, CD4 T cells, and CD8 T cells. Although CD11c+ 
CD205+ cells and macrophages (CD14+ CD68+) were not the majority population in the 
lymph nodes, non-vaccinated animal CLN contained significantly fewer CD11c+ cells than 
vaccinated CLN (P < 0.05). B cells were also present at significantly lower numbers in non-
vaccinated CLN, which correlates to the few germinal centers inside the lymph node (P < 
0.05). No difference was seen in the numbers of macrophages, CD4 T cells, and CD8 T cells 
between two groups. Less than 10% CD4+ T cells expressed CD25 marker on the cell surface 
in both groups. Overall, CLN from vaccinated and non-vaccinated animals contained similar 
numbers of CD4+ CD25+ T cells (Figure 2B).  
Phenotypic features of CD11c+ cells in the lymph nodes draining M. 
paratuberculosis inoculation site (CLN). CD11c+ cells were assessed for selected 
markers including CD14, CD205 (DEC205), MHC I and MHC II surface expression by flow 
cytometry (Figure 3). Lymph node CD11c+ cells expressed negative (below detection) CD14 
on the cell surface, which suggested that these cells were not macrophages (CD14high). 
Lymph node CD11c+ cells expressed medium to high level CD205 marker independent of 
infection status (Figure 3), which belongs to the macrophage mannose receptor family of C-
type lectin endocytic receptors and behaves as an antigen uptake/processing receptor for 
dendritic cells (Gliddon et al., 2004; Reiling et al., 2002). In vaccinated animals, CLN 
CD11c+ cells tended to have a higher level of CD205 surface expression compared to non-
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vaccinated animals (Figure 3), also the numbers of CD205high CD11c+ cells were higher in 
vaccinated animal CLN (data not shown). As expected for lymph node DC-like cells, 
expression of MHC I and MHC II on lymph node CD11c+ cells was high (Figure 3). 
Vaccinated animal CLN CD11c+ cells expressed highest level of MHC I and MHC II on 
surface. Non-vaccinated animal CLN DC expressed similar levels of MHC I and MHC II as 
DC in saline control LN. The percentage of cells positive for these two markers was about 
the same between lymph nodes from vaccinated and non-vaccinated groups, while both were 
significantly higher than monocyte-derived dendritic cells (p < 0.05, data not shown).  
Function of CD11c+ DC-like cells in the lymph node draining M. paratuberculosis 
inoculation site (CLN). In order to evaluate the function of CD11c+ cells in the CLN, the 
capacity of these cells to induce lymph node CD4 T (Figure 4) and CD8 T (Figure 5) 
lymphocyte proliferation was determined. CLN DC were co-cultured with lymphocytes from 
same lymph node.  
The population of proliferated CD4 T lymphocytes (CD4+ PKH67low) was 
significantly smaller in non-vaccinated animals DC-lymphocyte co-cultures than in 
vaccinated animals (Figure 4A). Proliferation index (Modfit software) showed similar results 
that CD4 T cells proliferated at a higher level in vaccinated animal co-cultures (P < 0.05, 
Figure 4B). The total numbers of CD4+ T lymphocytes recovered from the non-vaccinated 
animals DC-lymphocyte co-cultures were lower than vaccinated animals (P < 0.05, Figure 
4C), suggesting lower level CD4 T cell proliferation and possible cell death. As a control, 
lymphocytes were cultured alone in PPD without DC, and these cells had minimum 
proliferation (data not shown).  
A significantly larger population of proliferated CD8 T lymphocytes (CD8+ 
PKH67low) was present in the non-vaccinated animal DC-lymphocyte co-cultures (Figure 5). 
Also, spontaneous and ConA induced CD8 T cell proliferation seems to be higher in non-
vaccinated animal group. These data suggest that 60 days post M. paratuberculosis 
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inoculation, previous vaccination status may dampen the CD8 T lymphocyte response in the 
draining lymph node.  
In DC-lymphocyte co-cultures, intracellular IFN-γ and IL-4 production was 
measured. As shown in Figure 6, in antigen stimulated DC-lymphocyte co-cultures from non-
vaccinated animals, lymphocytes produced significantly lower level of IFN-γ (Figure 6A). 
More than 60% lymphocytes in vaccinated animal co-cultures produced IFN-γ, compared to 
20% in non-vaccinated group. Interestingly, lymphocytes in co-cultures from both vaccinated 
and non-vaccinated animals produced IL-4 (Figure 6B).  
IL-12 and IL-10 in the DC-lymphocyte co-cultures were also determined by ELISA. 
We found high levels of IL-10 and IL-12 in co-cultures from vaccinated and non-vaccinated 
animals (Figure 7). CLN DC by themselves produced little IL-10. However, the addition of 
CLN lymphocytes to DC culture induced high IL-10 secretion (P < 0.05, Figure 7B), which 
is independent of prior vaccination status. IL-10 may be produced by both DC and the T 
lymphocytes that have a regulatory function in the co-cultures.  
Discussion 
In this study, we evaluated the role of vaccination on lymph node cellular 
composition, and phenotypic and functional features of the lymph node CD11c+ DC-like 
cells in nodes draining M. paratuberculosis inoculation sites. 
We set out to answer the question “does vaccination have effects on differentiation, 
maturation, and function of antigen-presenting cells, specifically dendritic cells, which 
influence the immune response to subsequent M. paratuberculosis infection”. To our 
knowledge, this is the first study to determine the phenotype and function of dendritic cells in 
the lymph node directly draining M. paratuberculosis infection sites.  
The results of this study demonstrate that there are quantitative and qualitative 
differences between the immune response of non-vaccinated and vaccinated calves to 
challenge with live M. paratuberculosis. Lymph nodes draining the M. paratuberculosis 
 136
infection site (CLN) in immune animals were more reactive than those in non-vaccinated 
animals which was demonstrated by higher numbers of cortical lymphoid follicles 
histologically.  Flow cytometric analysis showed that vaccinated animals challenge side 
lymph nodes (CLN) contained higher numbers of CD11c+ CD205+ cells and B cells. More 
CD11c+ cells in the draining lymph node may be the result of high level antigen-encountered 
dendritic cells migration from M. paratuberculosis inoculation site to the lymph node. In 
support of this interpretation we have previously demonstrated that the M. paratuberculosis 
vaccine induces high CCR7 (chemokine receptor 7) expression on the inoculation site 
CD11c+ cells (data in preparation for publication).  
These CLN CD11c+ cells had a characteristic pattern of surface marker expression for 
lymph node dendritic cells, with negative CD14 and high CD205, MHC I and MHC II 
molecules. Our previous report and other studies showed that immature bovine DC have 
detectable, but low CD14 expression (Bajer et al., 2003; Hope et al., 2003; Langelaar et al., 
2005b; Lei and Hostetter, 2007; Miyazawa et al., 2006; Norimatsu et al., 2003; Pinchuk et 
al., 2003). This fact together with the finding that CD11c+ cells from CLN do not express 
CD14 suggest that M. paratuberculosis may also mediate the internalization of membrane 
form CD14 (mCD14), which was shown to happen when LPS interacts with CD14 (Rabehi 
et al., 2001; Wright, 1995). In vaccinated animals, a more mature DC phenotype was present 
with higher MHC I and MHC II surface expression. This may be attributed to the vaccine 
inducing generation of memory T cells, which can quickly release high level of cytokines, 
including IFN-γ, upon M. paratuberculosis challenge. IFN-γ is known to be a potent inducer 
of DC activation and maturation (Demangel et al., 2001; Dillon et al., 1998; Miro et al., 
2006). Vaccinated animals CLN contained high numbers of B cells, and B cells as a cellular 
source of cytokines, chemokines, and antibodies are also involved in the process of 
maturation and function of DC (Bayry et al., 2005). 
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Consistent with the high MHC I and II surface expression, CLN CD11c+ cells from 
both vaccinated and non-vaccinated animals induced an antigen-specific CD4 T cell 
response, with a higher level of proliferation in the vaccinated animal CLN. Surprisingly, the 
PPD antigen-specific CD8 T cell response was higher in the non-vaccinated animal CLN co-
cultures. From CLN cell composition analysis data, there was no significant difference in the 
number of CD8 T cells present in CLN from either immune or non-vaccinated animals. High 
expression of CD205 appears to be a marker for the lymph node dendritic cells that have 
regulatory effects on CD8 T cell responses (Kronin et al., 2000). Hence, the low CD8 T cell 
proliferation in vaccinated animal CLN may relate to the higher CD205 surface expression 
on the DC in these tissues. Further research needs to be done to elucidate whether there are 
differences in the function and cytolitic ability of these CD8 T cells.  
Local cytokine environment affects antigen-presenting cell function, effector T cell 
differentiation, and adaptive response polarization. We showed in this study that the CLN 
DC-lymphocyte co-cultures contained high levels of IL-10 and IL-12 in both immune and 
non-vaccinated animals. IL-10 may be produced by both lymph node DC and regulatory T 
cells, since in DC culture without lymphocytes less IL-10 was produced than in the co-
cultures.  This suggested IL-10 production by T cells, potentially regulatory cells. By flow 
cytometry, approximately 10% of total CLN CD4+ T cells also expressed CD25 marker in 
both immune and non-vaccinated animals. Whether these CD4+ CD25+ T cells have a 
regulatory function needs to be determined in the future work. High percentage of 
lymphocytes in vaccinated animals DC-lymphocyte co-cultures proliferated and produced 
IFN-γ and IL-4. Fewer IFN-γ producing lymphocytes were present in the non-vaccinated 
animals co-cultures. However, these lymphocytes produced high level of IFN-γ when they 
were co-cultured with ConA, suggesting under proper stimulation lymphocytes in non-
vaccinated animals could produce IFN-γ. We did not see a difference in the IL-12 secretion 
by CLN DC between two groups. The high IFN-γ production in immune animal upon 
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challenge could be due to the high production of other IFN-γ inducing cytokines by DC, like 
IL-18. It could also be the inhibitory or regulatory effects of CLN DC on lymphocytes 
proliferation and IFN-γ production in non-vaccinated animals. Non-vaccinated animals CLN 
CD11c+ cells expressed lower levels of MHC I and MHC II, and induced lower level CD4 T 
cell proliferation. Proliferated lymphocytes produced IL-4, but low IFN-γ. Both non-
vaccinated and vaccinated animals CLN DC-lymphocyte co-cultures contained high IL-10. 
Taken together, these results suggest that CLN DC in non-vaccinated animals may induce a 
biased regulatory or anti-inflammatory immune response to M. paratuberculosis infection, 
while CLN DC in vaccinated animals promoting a mixed Th1/Th2, pro- and anti-
inflammatory immune response. High IFN-γ in vaccinated animal CLN co-cultures could 
also be the result of the presence of memory T cells in immune animal which can proliferate 
better and generate IFN-γ rapidly after M. paratuberculosis challenge. Further work is 
required to confirm the presence and function of effector memory T cells, possibly through 
surface marker CD45RO, CD62L flow cytometry analysis.  
Our interpretation of these data is that the cytokine environment within the M. 
paratuberculosis infection site in vaccinated animals promotes DC maturation, thus the high 
migrating ability of DC, high numbers of DC in the DLN, high MHC I and MHC II 
expression on DC, and high CD4 T cell proliferation. These cytokines may be produced at 
least partly by memory cells generated by prior vaccination that migrate into the infection 
site upon the M. paratuberculosis challenge. IFN-γ is known to be a potent inducer of DC 
activation and maturation, including induction of cytokine IL-12 and costimulatory 
molecules up-regulation (Demangel et al., 2001; Dillon et al., 1998; Miro et al., 2006). 
Studies on BCG vaccinated cattle indicate that memory CD4 T cells and CD8 T cells are 
generated by BCG vaccination, and PPD pulsed DC can induce these T cells to proliferate 
and produce IFN-γ (Hope et al., 2000). Also, during M. tuberculosis chronic infection, a 
subset of CD8+ T cells develop into a central memory phenotype, which will expand and 
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produce IFN-γ upon re-challenge (Kamath et al., 2006). In addition to IFN-γ production by 
CD4 and CD8 T cells, bovine WC1+ γδ T cells were shown to be able to differentiate into a 
memory population and produce IFN-γ under the influence of a killed bacterial vaccine 
(Blumerman et al., 2007; Kamath et al., 2006). γδ T cells can promote dendritic cell 
maturation through the production of soluble factors including IFN-γ, and also cell-cell 
contact mechanism involving CD1 expression on γδ T cells may also play a role (Leslie et 
al., 2002; Shrestha et al., 2005). Our current hypothesis is that the M. paratuberculosis 
vaccination results in generation of memory T cells, which upon M. paratuberculosis 
challenge infiltrate into the infection site and have a better capacity to proliferate and produce 
cytokines. These cytokines in turn promote antigen-encountered DC at infection site to 
undergo complete activation, maturation, and migrate into the draining lymph node to expand 
the immune response.   
Overall, the results from this study show that in vaccinated animals, lymph nodes 
draining M. paratuberculosis infection sites had higher DC infiltration, likely from the 
infection site. These lymph node DC maintain a mature phenotype and induce high CD4 T 
lymphocyte antigen-specific proliferation and IFN-γ, IL-4 production.  
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Figure 1. Histology of lymph nodes draining (DLN) the M. paratuberculosis injection site in 
vaccinated (D) or non-vaccinated (C) calves 60 days post challenge. DLN of saline (A) or 
vaccine (B) injection site are also shown in the figure as negative and positive controls 
respectively. M. paratuberculosis site DLN from both vaccinated and non-vaccinated 
animals were enlarged. Morphologically, compared to non-vaccinated animal (C), vaccinated 
animal lymph node draining the M. paratuberculosis inoculation site (D) appeared to be in a 
reactive state and contained more germinal centers. Magnification 10X. Representative 
images from three non-vaccinated animals and six vaccinated animals are shown here, all 
animals were challenge with live M. paratuberculosis. 
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Figure 2. Cellular composition is different in the lymph nodes draining the M. 
paratuberculosis injection site (CLN) in vaccinated and non-vaccinated calves 60 days post 
challenge. (A). M. paratuberculosis site draining lymph nodes (CLN) from non-vaccinated 
animal contained significantly fewer CD11c+ CD205+ DC and B cells. CLN from both 
vaccinated and non-vaccinated animals had comparable numbers of macrophages, CD4+ T 
cells, CD8+ T cells. (B). Approximately 10% of CD4+ T lymphocytes in the DLN from both 
groups also expressed marker CD25 on the cell surface. No significant difference in the 
number of CD4+ CD25+ T cells was found. * means p < 0.05. Data are from six vaccinated 
animals and three non-vaccinated, all animals were challenge with live M. paratuberculosis 
60 days post vaccination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 147
 
 
 
 
 
 
 
 
 
 
 
 148
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Selected surface marker expression on CD11c+ DC-like cells recovered from lymph 
nodes draining M. paratuberculosis injection site (CLN) in either vaccinated or non-
vaccinated animals. Lymph node CD11c+ cells were negative for CD14 and positive for 
CD205 surface expression. These cells all expressed high levels of MHC I and MHC II. 
Vaccinated animal CLN CD11c+ cells tended to have a relatively higher MHC I and MHC II 
surface expression, although it was not statistically significant. Non-vaccinated animal CLN 
CD11c+ cells had a similar pattern of surface marker expression as the cells in the control 
lymph node draining saline control site. Isotype control is shown in red, sample in green. 
Data are representative flow plots from six vaccinated animals and three non-vaccinated, all 
animals were challenge with live M. paratuberculosis 60 days post vaccination. 
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Figure 7. IL-12 and IL-10 secretion in the M. paratuberculosis challenge site DLN (CLN) 
DC-lymphocyte co-culture supernatant as determined by ELISA. Peripheral blood monocyte-
derived DC (MD-DC) cultured alone or with peripheral blood T cells (pT) were shown as 
controls. (A). CLN DC produced high level IL-12 in the presence of CLN T cells and PPD, 
and the secretion was independent of vaccination status. CLN DC alone produced baseline 
level IL-12. (B). Significantly higher level of IL-10 protein was detected in the CLN DC -
lymphocyte co-culture, which was also independent of vaccination status (p < 0.05). Without 
PPD and CLN lymphocyte in culture, IL-10 level dropped to baseline level. MD-DC did not 
respond to in vitro PPD stimulation to secrete IL-10 and IL-12. Data are from six vaccinated 
animals and three non-vaccinated, all animals were challenged with live M. paratuberculosis 
60 days post vaccination. 
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CHAPTER FIVE. General Conclusion 
Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) is a 
pathogenic bacillus causing severe granulomatous enteritis and lymphadenitis in ruminants 
and is a public health concern (Harris and Barletta, 2001). The current M. paratuberculosis 
vaccine is not completely effective in preventing the disease (Chiodini et al., 1984; Cocito et 
al., 1994; Kormendy, 1994; van Schaik et al., 1996). There is a need for better understanding 
of the immune response following vaccination, which will provide valuable information for 
future vaccine design. The early immune response to M. paratuberculosis infection 
determines the control of this intracellular pathogen infection and the type of adaptive 
immune response against infection. Dendritic cells (DC), as the first line of defense in innate 
immunity and also inducers and regulators of adaptive immunity, play an essential role in the 
control of mycobacterial infection. Limited information is available describing how M. 
paratuberculosis infection affects dendritic cells (DC) function and the role of DC in the 
formation and organization of M. paratuberculosis induced granuloma. Given the central role 
of DC in the initiation and regulation of the host immune response, the studies described in 
this dissertation examined the modulation of DC by M. paratuberculosis, and also the effects 
of M. paratuberculosis vaccination on the DC function upon M. paratuberculosis challenge.  
First, phenotype and function of bovine monocyte-derived DC infected with M. 
paratuberculosis were determined. M. paratuberculosis infected monocyte-derived DC 
showed some evidences of maturation, but were unable to present antigen via MHC II and 
produce pro-inflammatory cytokines. Secondly, M. paratuberculosis subcutaneous infection 
model system was used to study DC function in M. paratuberculosis infection in vivo. 
Compared to M. paratuberculosis vaccine induced granulomas, CD11c+ DC-like cells were 
present at lower numbers and had an incomplete maturation phenotype within M. 
paratuberculosis induced granulomas. These DC-like cells induced antigen-specific CD4 T 
cell response while providing poor co-stimulation and cytokine signals. Thirdly, the 
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maturation status and function of DC in the lymph node draining M. paratuberculosis 
infection site were determined. It was shown in a recent report that M. bovis BCG vaccinated 
mice had enhanced macrophage activity upon M. tuberculosis challenge (Ordway et al., 
2006). We tested the hypothesis that M. paratuberculosis vaccination affects the function of 
antigen presenting cells, especially DC function, upon M. paratuberculosis challenge. 
Greater numbers of DC-like cells and B cells were found in the lymph node draining M. 
paratuberculosis challenge side (CLN) in vaccinated animal. These DC-like cells had a 
mature phenotype and produced high levels of IL-12 and IL-10. Vaccinated animals CLN 
had high CD4 T lymphocyte recall response upon stimulation with antigen-loaded DC and 
produced high levels of IFN-γ and IL-4. Together, these data suggest an effect of M. 
paratuberculosis vaccine on DC function at challenge.  
In general, the studies in this dissertation demonstrate that M. paratuberculosis 
infects DC, which results in incomplete activation and maturation of infected cells. M. 
paratuberculosis infected DC are unable to provide optimal co-stimulatory and cytokine 
signals to antigen-specific T lymphocytes, and result in low IFN-γ production by these 
lymphocytes. M. paratuberculosis vaccination affects DC function upon M. paratuberculosis 
challenge, inducing a mixed pro- and anti-inflammatory response.  
Specific Aim One 
This set of experiments determined the phenotype, function, and maturation status of 
bovine monocyte-derived dendritic cells following M. paratuberculosis infection in vitro. 
There are differences in the function and maturation of M. paratuberculosis infected DC 
compared with DC infected by other mycobacteria. Whole bacterium M. tuberculosis or 
BCG infects DC, induces DC maturation, and a Th1 biased immune response with increased 
IL-12 production (Giacomini et al., 2001; Henderson et al., 1997; Hickman et al., 2002; Kim 
et al., 1999). Virulent M. tuberculosis has also been shown to inhibit full maturation of 
human monocyte-derived DC (Hanekom et al., 2003). The results described here suggest that 
 163
M. paratuberculosis infects DC and induces incomplete DC maturation with low IL-12, but 
high IL-10 secretion.  
Healthy steers were used in the study to generate monocyte-derived DC. The pattern 
of surface marker expression on bovine monocyte-derived DC was low CD14, moderate to 
high levels of MHC II, MHC I, CD11c, CD172a, and CD1b. M. paratuberculosis infected 
DC had up-regulated CD40, CD80, and CCR7 gene expression. Functionally, M. 
paratuberculosis infected DC were unable to endocytose DQ-ovalbumin. Fully matured DC 
cannot take up antigen and express high levels of MHC I, MHC II, CD40, CD80, CCR7, 
therefore M. paratuberculosis infected DC achieved some aspects of mature DC. However, 
live M. paratuberculosis infection did not increase MHC II surface expression contrary to 
what was expected. The capacity of M. paratuberculosis infected DC to induce T cell 
proliferation was low. Infected DC secreted low pro-inflammatory cytokine IL-12 yet high 
anti-inflammatory IL-10. Together, these data suggest that M. paratuberculosis infection 
induce a semi-mature DC phenotype.  
Specific Aim Two 
These studies determined the phenotypic and functional features of CD11c+ DC-like 
cells in granulomatous lesion induced by M. paratuberculosis infection in vivo. We further 
tested our in vitro work results in an in vivo subcutaneous M. paratuberculosis infection 
model system.  Morphologically, diffuse granulomatous inflammation that lacks organization 
was seen at the M. paratuberculosis inoculation site 7 days post infection. While at the 
vaccination site, diffuse granulomatous inflammation with some degree of organization was 
present. Individual nodules were beginning to form at the vaccination site and were separated 
by fibrous tissue. This is associated with high TNF-α expression in vaccine induced 
granulomas. The cellular composition was different in M. paratuberculosis and vaccine 
induced granulomatous lesions, with fewer CD11c+ CD205+ cells (DC-like cells), 
macrophages, and CD4+ T lymphocytes present in the M. paratuberculosis induced 
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granulomas. To analyze total cells and DC gene expression within granulomatous lesions, 
granuloma cells and DC were isolated directly from the lesions via laser capture 
microdissection. The cytokine environment in M. paratuberculosis induced granulomas was 
low in IFN-γ, TNF-α, IL-4, and TGF-β compared to vaccine induced granulomas. M. 
paratuberculosis induced granuloma DC-like cells expressed a medium to high level MHC I 
and MHC II, low CD40, CD80, CD86 and CCR7, and produced low IL-12 and IL-10 
compared to vaccine granuloma DC. M. paratuberculosis granuloma DC induced CD4 T 
lymphocyte antigen specific proliferation, yet these proliferated T cells produced low levels 
of IFN-γ and IL-4, which is consistent with the low IL-12 and IL-10 level. Overall, these 
results demonstrate that M. paratuberculosis in vivo infection induces incomplete DC 
maturation at infection site, which in turn leads to suboptimal T cell and cytokine responses.  
Specific Aim Three 
Data obtained from these studies indicate that M. paratuberculosis vaccination affects 
the phenotype and function of antigen presenting cells, including DC function. Non-
vaccinated animals DC within lymph nodes draining M. paratuberculosis challenge sites had 
gone through incomplete maturation and were unable to induce a protective Th1 immune 
response. 
In vaccinated animals, the lymph nodes draining the challenge sites (CLN) appeared 
to be in an activated state with many germinal centers. More CD11c+ CD205+ DC-like cells 
and B cells were found in the vaccinated animal CLN. No difference was seen in the number 
of CD4 T cells, CD8 T cell, and macrophages between two groups. Vaccinated animal CLN 
DC had a mature phenotype with high MHC I and MHC II expression and produced high 
levels of IL-12 and IL-10. CD4 T cells in vaccinated animal CLN had a higher antigen-
specific recall response and produced high IFN-γ and IL-4. While the DC in non-vaccinated 
animals CLN had suboptimal MHC I and MHC II expression, lower capacity to induce CD4 
T cell proliferation, and high IL-10 production. In turn, the proliferated T cells induced by 
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these DC produced low IFN-γ but high IL-4. So, CLN DC with an incomplete mature 
phenotype in non-vaccinated animals tended to induce a IL-4, IL-10 mediated regulatory 
response. CD8 recall response was low in vaccinated animals CLN, which may be due partly 
to the high CD205 expression on these DC since high expression of CD205 was shown to be 
a marker for the lymph node dendritic cells that have regulatory effects on CD8 T cell 
responses (Kronin et al., 2000). Overall, these data point to the fact that prior M. 
paratuberculosis vaccination induce antigen presenting cells activation and maturation upon 
challenge at the infection site. This effect is possibly mediated through the memory T and B 
cells generated by vaccination. Memory cells can promote DC maturation at the infection site 
by producing cytokines like IFN-γ. The presence and function of memory T cells in M. 
paratuberculosis vaccinated calves need to be determined in the future study.  
Taken together, the studies in this dissertation provide important information in 
understanding the early immune response following M. paratuberculosis infection, the 
initiation of adaptive immune response, and the phenotype and function of DC in M. 
paratuberculosis infection and granuloma formation. These results indicate that M. 
paratuberculosis infects DC and results in impaired or incomplete DC activation and 
maturation. M. paratuberculosis infected, incompletely matured DC can not provide optimal 
co-stimulatory and pro-inflammatory cytokine signals to induce a sustained protective T cell 
immune response.  
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